Sturm, Ruger & Company (RGR) 10-K 19 Feb 25 2024 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Dec. 31, 2024	Feb. 10, 2025	Jun. 30, 2024
Document Information [Line Items]
Document Type	10-K
Document Annual Report	true
Document Transition Report	false
Document Financial Statement Error Correction [Flag]	false
Entity Interactive Data Current	Yes
ICFR Auditor Attestation Flag	true
Amendment Flag	false
Document Period End Date	Dec. 31, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY
Documents Incorporated by Reference [Text Block]	Portions of the registrant’s Proxy Statement relating to the 2025 Annual Meeting of Stockholders to be held May 29, 2025 are incorporated by reference into Part III (Items 10 through 14) of this Report.
Entity Information [Line Items]
Entity Registrant Name	STURM, RUGER & COMPANY, INC.
Entity Central Index Key	0000095029
Entity File Number	001-10435
Entity Tax Identification Number	06-0633559
Entity Incorporation, State or Country Code	DE
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Public Float			$ 771,970,000
Entity Contact Personnel [Line Items]
Entity Address, Address Line One	1 Lacey Place
Entity Address, City or Town	Southport
Entity Address, State or Province	CT
Entity Address, Postal Zip Code	06890
Entity Phone Fax Numbers [Line Items]
City Area Code	(203)
Local Phone Number	259-7843
Entity Listings [Line Items]
Title of 12(b) Security	Common Stock, $1 par value
Trading Symbol	RGR
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		16,762,100

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2024
Auditor [Table]
Auditor Name	RSM US LLP
Auditor Firm ID	49
Auditor Location	Stamford, Connecticut
Auditor Opinion [Text Block]	Opinion on the Financial Statements We have audited the accompanying consolidated balance sheets of Sturm, Ruger & Company, Inc. and its subsidiaries (the Company) as of December 31, 2024 and 2023, the related consolidated statements of income and comprehensive income, stockholders' equity and cash flows for each of the three years in the period ended December 31, 2024, and the related notes to the consolidated financial statements and schedule (collectively, the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Current Assets
Cash and cash equivalents	$ 10,028	$ 15,174
Short-term investments	95,453	102,485
Trade receivables, net	67,145	59,864
Gross inventories	149,417	150,192
Less LIFO reserve	(66,398)	(64,262)
Less excess and obsolescence reserve	(6,533)	(6,120)
Net inventories	76,486	79,810
Prepaid expenses and other current assets	9,245	14,062
Total Current Assets	258,357	271,395
Property, plant and equipment	477,622	462,397
Less allowances for depreciation	(406,373)	(390,863)
Net property, plant and equipment	71,249	71,534
Deferred income taxes	16,681	11,976
Other assets	37,747	43,912
Total Assets	384,034	398,817
Current Liabilities
Trade accounts payable and accrued expenses	35,750	31,708
Contract liabilities with customers (Note 2)		149
Product liability	431	634
Employee compensation and benefits	18,824	24,660
Workers’ compensation	5,804	6,044
Total Current Liabilities	60,809	63,195
Lease liability (Note 7)	1,747	2,170
Employee compensation	1,835	1,685
Product liability accrual	61	46
Contingent liabilities (Note 20)
Stockholders’ Equity
Additional paid-in capital	50,536	46,849
Retained earnings	436,609	418,058
Less: Treasury stock – at cost 2024 – 7,677,159 shares 2023 – 6,978,400 shares	(192,031)	(157,623)
Total Stockholders’ Equity	319,582	331,721
Total Liabilities and Stockholders’ Equity	384,034	398,817
Nonvoting Common Stock
Stockholders’ Equity
Common Stock, Value
Common Stock
Stockholders’ Equity
Common Stock, Value	$ 24,468	$ 24,437

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - $ / shares	Dec. 31, 2024	Dec. 31, 2023
Treasury stock, shares	7,677,159	6,978,400
Nonvoting Common Stock
Common stock, par value (in Dollars per share)	$ 1	$ 1
Common stock, shares authorized	50,000	50,000
Common stock, shares issued
Common Stock
Common stock, par value (in Dollars per share)	$ 1	$ 1
Common stock, shares authorized	40,000,000	40,000,000
Common stock, shares issued	24,467,983	24,437,020
Common stock, shares outstanding	16,790,824	17,458,620

Consolidated Statements of Inco

Consolidated Statements of Income and Comprehensive Income - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Total net sales	$ 535,643	$ 543,767	$ 595,842
Cost of products sold	421,228	410,148	415,757
Gross profit	114,415	133,619	180,085
Operating Expenses (Income):
Selling	38,755	38,788	36,114
General and administrative	44,006	42,752	40,551
Other operating income, net		(5)	(36)
Total operating expenses	82,761	81,535	76,629
Operating income	31,654	52,084	103,456
Other income:
Royalty income	857	658	837
Interest income	4,885	5,465	2,552
Interest expense	(102)	(205)	(256)
Other income, net	481	822	1,690
Total other income, net	6,121	6,740	4,823
Income before income taxes	37,775	58,824	108,279
Income taxes	7,212	10,609	19,947
Net income and comprehensive income	$ 30,563	$ 48,215	$ 88,332
Basic earnings per share (in Dollars per share)	$ 1.79	$ 2.73	$ 5
Diluted earnings per share (in Dollars per share)	$ 1.77	$ 2.71	$ 4.96
Weighted average number of common shares outstanding - Basic (in Shares)	17,088,205	17,676,955	17,648,850
Weighted average number of common shares outstanding - Diluted (in Shares)	17,270,101	17,811,218	17,793,348
Cash dividends per share (in Dollars per share)	$ 0.69	$ 6.27	$ 2.42
Net firearms sales
Total net sales	$ 532,608	$ 540,746	$ 593,289
Net castings sales
Total net sales	$ 3,035	$ 3,021	$ 2,553

Consolidated Statements of Stoc

Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Retained Earnings	Treasury Stock	Total
Balance at Dec. 31, 2021	$ 24,306	$ 46,847	$ 438,098	$ (145,590)	$ 363,661
Net income			88,332		88,332
Dividends paid			(42,718)		(42,718)
Stock-based compensation		1,671			1,671
Vesting of RSU’s		(3,371)			(3,371)
Common stock issued – compensation plans	72	(72)
Unpaid dividends accrued			(90,615)		(90,615)
Repurchase of shares of common stock				(222)	(222)
Balance at Dec. 31, 2022	24,378	45,075	393,097	(145,812)	316,738
Net income			48,215		48,215
Dividends paid			(22,446)		(22,446)
Stock-based compensation		3,989			3,989
Vesting of RSU’s		(2,156)			(2,156)
Common stock issued – compensation plans	59	(59)
Unpaid dividends accrued			(808)		(808)
Repurchase of shares of common stock				(11,811)	(11,811)
Balance at Dec. 31, 2023	24,437	46,849	418,058	(157,623)	331,721
Net income			30,563		30,563
Dividends paid			(11,829)		(11,829)
Stock-based compensation		4,342			4,342
Vesting of RSU’s		(624)			(624)
Common stock issued – compensation plans	31	(31)
Unpaid dividends accrued			(183)		(183)
Repurchase of shares of common stock				(34,408)	(34,408)
Balance at Dec. 31, 2024	$ 24,468	$ 50,536	$ 436,609	$ (192,031)	$ 319,582

Consolidated Statements of St_2

Consolidated Statements of Stockholders’ Equity (Parentheticals) - shares	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Stockholders' Equity [Abstract]
Repurchase of common stock	835,060	264,062	4,440

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Operating Activities
Net income	$ 30,563	$ 48,215	$ 88,332
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	22,063	22,383	25,789
Stock-based compensation	4,342	3,989	1,671
Excess and obsolescence inventory reserve	413	1,308	501
Gain on sale of assets		(5)	(36)
Deferred income taxes	(4,705)	(5,867)	(5,573)
Changes in operating assets and liabilities:
Trade receivables	(7,281)	5,585	(8,413)
Inventories	2,911	(16,125)	(21,644)
Trade accounts payable and accrued expenses	3,789	(4,406)	(640)
Contract liability with customers	(149)	(882)	1,031
Employee compensation and benefits	(5,869)	(6,469)	(3,420)
Product liability	(188)	372	(584)
Prepaid expenses, other assets and other liabilities	9,615	(13,026)	(954)
Income taxes receivable/payable		(1,171)	1,171
Cash provided by operating activities	55,504	33,901	77,231
Investing Activities
Property, plant and equipment additions	(20,821)	(15,796)	(27,730)
Purchases of short-term investments	(138,885)	(192,627)	(365,480)
Proceeds from maturity of short-term investments	145,917	249,274	406,319
Net proceeds from sale of assets		5	100
Cash (used for) provided by investing activities	(13,789)	40,856	13,209
Financing Activities
Dividends paid	(11,829)	(110,789)	(42,718)
Repurchase of common stock	(34,408)	(11,811)	(222)
Payment of employee withholding tax related to share-based compensation	(624)	(2,156)	(3,371)
Cash used for financing activities	(46,861)	(124,756)	(46,311)
(Decrease) increase in cash and cash equivalents	(5,146)	(49,999)	44,129
Cash and cash equivalents at beginning of year	15,174	65,173	21,044
Cash and cash equivalents at end of year	$ 10,028	$ 15,174	$ 65,173

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2024
Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	1. Summary of Significant Accounting Policies Organization Sturm, Ruger & Company, Inc. (the “Company”) is principally engaged in the design, manufacture, and sale of firearms to domestic customers. Approximately 99% of sales were from firearms. Export sales represented approximately 5% of firearms sales. The Company’s design and manufacturing operations are located in the United States and almost all product content is domestic. The Company’s firearms are sold through a select number of independent wholesale distributors principally to the commercial sporting market. The Company manufactures investment castings made from steel alloys and metal injection molding (“MIM”) parts for internal use in its firearms and utilizes available capacity to manufacture and sell investment castings and MIM parts to unaffiliated, third-party customers. Castings were less than 1% of the Company’s total sales for the year ended December 31, 2024. Preparation of Financial Statements The Company follows United States generally accepted accounting principles (“GAAP”). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. The significant accounting policies described below, together with the notes that follow, are an integral part of the consolidated financial statements. Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated. Revenue Recognition The Company recognizes revenue in accordance with the provisions of Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (“ASC 606”), which became effective January 1, 2018. Substantially all product sales are sold FOB (free on board) shipping point. Customary payment terms are 2% 30 days, net 40 days. Generally, all performance obligations are satisfied when product is shipped and the customer takes ownership and assumes the risk of loss. In some instances, sales include multiple performance obligations. The most common of these instances relates to sales promotion programs under which downstream customers are entitled to receive no charge products based on their purchases of certain of the Company’s products from the independent distributors. The fulfillment of these no charge products is the Company’s responsibility. In such instances, the Company allocates the revenue of the promotional sales based on the estimated level of participation in the sales promotional program and the timing of the shipment of all of the firearms included in the promotional program, including the no charge firearms. Revenue is recognized proportionally as each performance obligation is satisfied, based on the relative customary price of each product. Customary prices are generally determined based on the prices charged to the independent distributors. The net change in contract liabilities for a given period is reported as an increase or decrease to sales. The Company accounts for cash sales discounts as a reduction in sales. Amounts billed to customers for shipping and handling fees are included in net sales and costs incurred by the Company for the delivery of goods are classified as selling expenses. Federal excise taxes are excluded from net sales. Cash and Cash Equivalents The Company considers interest-bearing deposits with financial institutions with remaining maturities of three months or less at the time of acquisition to be cash equivalents. Fair Value Measurements of Short-term Investments Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the principal or most advantageous market at the measurement date. Fair value is established according to a hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below: Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs. Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data. Level 3: Unobservable inputs are used when little or no market data is available. Level 3 inputs are given the lowest priority in the fair value hierarchy. The asset or liability’s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs. As of December 31, 2024, the Company’s short-term investments consist of U.S. Treasury instruments (Level 1), maturing within one year, and . For the bank-managed money market fund, t . Such securities are classified as held to maturity, since the Company has the intent and ability to do so, and are carried at cost plus accrued interest, which approximates fair value. The fair value of inventory acquired as part of business combination is based on a third-party valuation utilizing the comparable sales method which is based on Level 2 and Level 3 inputs. The fair value of property, plant and equipment acquired as part of business combination is based on a third-party valuation utilizing the indirect method of cost approach, which is based on Level 2 and Level 3 inputs. The fair value of patents acquired as part of business combination is based on a third-party valuation utilizing the replacement cost method, which is based on Level 2 and Level 3 inputs. The fair value of the remaining intangible assets as part of business combination are based on a third-party valuation utilizing discounted cash flow methods that involves inputs, which are not observable in the market (Level 3). Accounts Receivable The Company establishes an allowance for doubtful accounts based on the creditworthiness of its customers and historical experience. While the Company uses the best information available to make its evaluation, future adjustments to the allowance for doubtful accounts may be necessary if there are significant changes in economic and industry conditions or any other factors considered in the Company’s evaluation. Bad debt expense has been immaterial during each of the last three years. The Company mitigates its credit risk by maintaining credit insurance on most of its significant customers. Inventories Substantially all of the Company’s inventories are valued at the lower of cost, principally determined by the last-in, first-out (LIFO) method, or net realizable value. Elements of cost in inventories include raw materials, direct labor and manufacturing overhead. Property, Plant and Equipment Property, plant and equipment are carried at cost. Depreciation is computed over useful lives using the straight-line and declining balance methods predominately over 15 years for buildings, 7 years for machinery and equipment and 3 years for tools and dies. When assets are retired, sold or otherwise disposed of, their gross carrying values and related accumulated depreciation are removed from the accounts and a gain or loss on such disposals is recognized when appropriate. Maintenance and repairs are charged to operations; replacements and improvements are capitalized. Long-lived Assets The Company evaluates the carrying value of long-lived assets to be held and used when events or changes in circumstances indicate the carrying value may not be recoverable. In performing this review, the carrying value of the assets is compared to the projected undiscounted cash flows to be generated from the assets. If the sum of the undiscounted expected future cash flows is less than the carrying value of the assets, the assets are considered to be impaired. Impairment losses are measured as the amount by which the carrying value of the assets exceeds their fair value. The Company bases fair value of the assets on quoted market prices if available or, if not available, quoted market prices of similar assets. Where quoted market prices are not available, the Company estimates fair value using the estimated future cash flows generated by the assets discounted at a rate commensurate with the risks associated with the recovery of the assets. As of December 31, 2024, the Company does not believe there are any indications of impairment related to long-lived assets. Goodwill The Company’s goodwill represents the excess of the purchase price of business combinations over the fair value of the net assets acquired. We assess goodwill for impairment on an annual basis during the fourth quarter of each year, and between annual tests whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment exists by the amount the fair value of a reporting unit to which goodwill has been allocated is less than their respective carrying values. The impairment for goodwill is limited to the total amount of goodwill allocated to the reporting unit. Goodwill impairment testing requires significant judgment and management estimates, including, but not limited to, the determination of (i) the number of reporting units, (ii) the goodwill and other assets and liabilities to be allocated to the reporting units and (iii) the fair values of the reporting units. The estimates and assumptions described above, along with other factors such as discount rates, will significantly affect the outcome of the impairment tests and the amounts of any resulting impairment losses. As of December 31, 2024, the Company does not believe there are any indications of impairment related to goodwill. Income Taxes Income taxes are accounted for using the asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences of “temporary differences” by applying enacted statutory rates applicable to future years to temporary differences between the financial statement carrying amounts and the tax basis of the Company’s assets and liabilities. Product Liability The Company provides for product liability claims including estimated legal costs to be incurred defending such claims. The provision for product liability claims is charged to cost of products sold. Advertising Costs The Company includes advertising costs in selling expenses and these costs are expensed as incurred. Advertising costs for 2024, 2023, and 2022, were $3.4 million, $3.1 million, and $2.4 million, respectively. Shipping Costs Costs incurred related to the shipment of products are included in selling expense. Such costs totaled $4.3 million, $4.4 million, and $4.7 million in 2024, 2023, and 2022, respectively. Research and Development In 2024, 2023, and 2022, the Company spent approximately $8.2 million, $9.8 million, and $9.6 million, respectively, on research and development activities relating to new products and the improvement of existing products. These costs are included in costs of products sold and are expensed as incurred. These costs are capitalized for tax purposes under the provisions of the Tax Cuts and Jobs Act of 2017 that relate to IRS Code Section 174, as discussed in Note 13. Earnings per Share Basic earnings per share is based upon the weighted-average number of shares of common stock outstanding during the year. Diluted earnings per share reflect the impact of restricted stock units and deferred stock outstanding using the treasury stock method. Recent Accounting Pronouncements In November of 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” The updated accounting guidance requires enhanced reportable segment disclosures, primarily related to significant segment expenses which are regularly provided to the chief operating decision maker. The guidance is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. The Company adopted ASU 2023-07, beginning with the current filing. The adoption of the new guidance required additional disclosures, but did not have a material impact to the Company. Refer to Note 17, Operating Segment Information, for the updated presentation. In December of 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” The updated accounting guidance requires expanded income tax disclosures, including the disaggregation of existing disclosures related to the effective tax rate reconciliation and income taxes paid. The guidance is effective for fiscal years beginning after December 15, 2024. Prospective application is required, with retrospective application permitted. The Company is currently evaluating the effect the updated guidance will have on its financial statement disclosures. In November 2024, the FASB issued ASU No. 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures,” which requires additional disclosure of certain costs and expenses within the notes to the financial statements. The updated standard is effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods within annual reporting periods beginning after December 15, 2027. The requirements will be applied prospectively with the option for retrospective application. Early adoption is permitted. The Company is currently evaluating the effect the updated guidance will have on its financial statement disclosures.

Revenue Recognition and Contrac

Revenue Recognition and Contracts with Customers	12 Months Ended
	Dec. 31, 2024
Revenue Recognition and Contracts with Customers [Abstract]
Revenue Recognition and Contracts with Customers	2. Revenue Recognition and Contracts with Customers The impact of ASC 60 6 on revenue recognized during the years ended December 31, 2024, December 31, 2023, and 2024 2023 2022 Contract liabilities with customers at January 1, $ 149 $ 1,031 $ — Revenue recognized (149 ) (4,084 ) — Revenue deferred — 3,202 1,031 Contract liabilities with customers at December 31, $ — $ 149 $ 1,031 During the year ended December 31, 2024, the Company did not defer any revenue and recognized $0.1 million of revenue previously deferred as the performance obligations relating to the shipment of free products were satisfied. This resulted in a net increase in firearms sales for the year ended December 31, 2024 of $0.1 million and there being no During the year ended December 31, 2023, the Company deferred $3.2 million of revenue, offset by the recognition of $4.1 million of revenue previously deferred as the performance obligations relating to the shipment of free products were satisfied. This resulted in a net increase in firearms sales for the year ended December 31, 2023 of $0.9 million and a deferred contract revenue liability at December 31, 2023 of $0.1 million. During the year ended December 31, 2022, the Company deferred $1.0 million of revenue. There was no offset for the recognition from previously deferred revenue as the Company did not satisfy any performance obligations relating to the shipment of free products during the year. This resulted in a net decrease in firearms sales for the year ended December 31, 2022 of $1.0 million and a deferred contract revenue liability at December 31, 2022 of $1.0 million. Practical Expedients and Exemptions The Company has elected to account for shipping and handling activities that occur after control of the related product transfers to the customer as fulfillment activities that are recognized upon shipment of the goods.

Trade Receivables, Net

Trade Receivables, Net	12 Months Ended
	Dec. 31, 2024
Trade Receivables, Net [Abstract]
Trade Receivables, Net	3. Trade Receivables, Net Trade receivables consist of the following: December 31, 2024 2023 Trade receivables $ 68,855 $ 61,428 Allowance for doubtful accounts (400 ) (400 ) Allowance for discounts (1,310 ) (1,164 ) $ 67,145 $ 59,864 In 2024, the largest individual trade receivable balances accounted for 26%, 20%, 14%, and 11% of total trade receivables, respectively. In 2023, the largest individual trade receivable balances accounted for 22%, 20%, and 17% of total trade receivables, respectively.

Inventories

Inventories	12 Months Ended
	Dec. 31, 2024
Inventories [Abstract]
Inventories	4. Inventories Inventories consist of the following: December 31, 2024 2023 Inventory at FIFO Finished goods $ 26,022 $ 30,989 Materials and products in process 123,395 119,203 Gross inventories 149,417 150,192 Less: LIFO reserve (66,398 ) (64,262 ) Less: excess and obsolescence reserve (6,533 ) (6,120 ) Net inventories $ 76,486 $ 79,810

Property, Plant and Equipment

Property, Plant and Equipment	12 Months Ended
	Dec. 31, 2024
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	5. Property, Plant and Equipment Property, plant and equipment consist of the following: December 31, 2024 2023 Land and improvements $ 2,826 $ 2,826 Buildings and improvements 76,153 74,650 Machinery and equipment 333,365 322,730 Dies and tools 65,278 62,191 Property, plant and equipment 477,622 462,397 Less allowances for depreciation (406,373 ) (390,863 ) Net property, plant and equipment $ 71,249 $ 71,534 Depreciation expense totaled $21.1 million, $21.1 million, and $24.4 million in 2024, 2023, and 2022, respectively.

Other Assets

Other Assets	12 Months Ended
	Dec. 31, 2024
Other Assets [Abstract]
Other Assets	6. Other Assets Other assets consist of the following: December 31, 2024 2023 Patents, at cost $ 10,339 $ 10,280 Deposits on capital items 18,443 23,045 Marlin trade name, at cost 7,800 7,800 Accumulated amortization (8,008 ) (7,171 ) Other 9,173 9,958 $ 37,747 $ 43,912 The capitalized cost of patents is amortized using the straight-line method over their useful lives. Expenses related to patent amortization was $0.5 million in 2024, $0.4 million in 2023, and $0.4 million in 2022. The estimated annual patent amortization expense for each of the next five years is $0.4 million. Costs incurred to maintain existing patents are charged to expense in the year incurred. The Marlin trade name will be amortized using the straight-line method over its useful life. The estimated annual trade name amortization cost for each of the next five years is $0.4 million. The intangible asset related to Marlin customer relationships are included in Other above and will be amortized using the straight-line method over its useful life. The estimated annual customer relationship name amortization expense for each of the next five years is $0.1 million.

Leased Assets

Leased Assets	12 Months Ended
	Dec. 31, 2024
Leased Assets [Abstract]
LEASED ASSETS	7. Leased Assets The Company leases certain of its real estate and equipment. The Company has evaluated all its leases and determined that all are operating leases under the definitions of the guidance of ASU 2016-02. The Company’s lease agreements generally do not require material variable lease payments, residual value guarantees or restrictive covenants. The Company uses the effective interest method to record right-of-use assets equal to the present value of the contractual liability for future lease payments. The table below presents the right-of-use assets and related lease liabilities recognized on the condensed consolidated balance sheet as of December 31, 2024: Balance Sheet Line December 31, December 31, Right-of-use assets Other assets $ 2,345 $ 2,781 Operating lease liabilities Current portion Trade accounts payable and accrued expenses $ 598 $ 611 Noncurrent portion Lease liabilities 1,747 2,170 Total operating lease liabilities $ 2,345 $ 2,781 The depreciable lives of right-of-use assets are limited by the lease term and are amortized on a straight line basis over the life of the lease. The Company’s leases generally do not provide an implicit interest rate, and therefore the Company calculates an incremental borrowing rate to determine the present value of its operating lease liabilities. The table below includes cash paid for our operating lease liabilities, other non-cash information, our weighted average remaining lease term and weighted average discount rate: Year Ended December 31, December 31, Cash paid for amounts included in the measurement of lease liabilities $ 796 $ 796 Cash amounts paid for short-term leases $ 449 $ 565 Right-of-use assets obtained in exchange for lease liabilities $ — $ — Weighted average remaining lease term (years) 7.7 7.9 Weighted average discount rate 8.0% 5.0% The following table reconciles the undiscounted future minimum lease payments to the total operating lease liabilities recognized on the condensed consolidated balance sheet as of December 31, 2024: 2025 $ 765 2026 771 2027 295 2028 160 2029 160 Thereafter 800 Total undiscounted future minimum lease payments 2,951 Less: Difference between undiscounted lease payments & the present value of future lease payments (606 ) Total operating lease liabilities $ 2,345 Certain of the Company’s lease agreements contain renewal options at the Company’s discretion. The Company does not recognize right-of-use assets or lease liabilities for leases of one year or less or for renewal periods unless it is reasonably certain that the Company will exercise the renewal option at the inception of the lease or when a triggering event occurs. The Company’s weighted average remaining lease term for operating leases as of December 31, 2024 is 7.7 years.

Trade Accounts Payable and Accr

Trade Accounts Payable and Accrued Expenses	12 Months Ended
	Dec. 31, 2024
Trade Accounts Payable and Accrued Expenses [Abstract]
Trade Accounts Payable and Accrued Expenses	8. Trade Accounts Payable and Accrued Expenses Trade accounts payable and accrued expenses consist of the following: December 31, 2024 2023 Trade accounts payable $ 13,170 $ 11,100 Federal excise taxes payable 13,192 11,954 Accrued other 9,388 8,654 $ 35,750 $ 31,708

Accrued Dividends

Accrued Dividends	12 Months Ended
	Dec. 31, 2024
Accrued Dividends [Abstract]
Accrued Dividends	9. Accrued Dividends On November 30, 2022, the Company’s Board of Directors declared a $5.00 per share special dividend payable on January 5, 2023 to stockholders of record as of December 15, 2022. The dividend, which totaled $88.3 million, was paid on January 5, 2023.

Line of Credit

Line of Credit	12 Months Ended
	Dec. 31, 2024
Line of Credit [Abstract]
Line of Credit	10. Line of Credit On January 7, 2022, the Company entered into a three-year, $40 million unsecured revolving line of credit agreement with a bank. On June 6, 2024, the Company amended its existing line of credit agreement, which now expires January 7, 2028. Borrowings under this new facility bear interest at the applicable Secured Overnight Financing Rate (SOFR), plus 150 basis points, plus an additional adjustment of eight basis points. The Company is also charged one-quarter of a percent (0.25%) per year on the unused portion. At December 31, 2024, the Company was in compliance with the terms and covenants of the credit facility.

Employee Benefit Plans

Employee Benefit Plans	12 Months Ended
	Dec. 31, 2024
Employee Benefit Plans [Abstract]
Employee Benefit Plans	11. Employee Benefit Plans The Company sponsors a qualified defined-contribution 401(k) plan that covers substantially all of its employees. Under the terms of the 401(k) plan, the Company matches a certain portion of employee contributions to their individual 401(k) accounts using the “safe harbor” guidelines provided in the Internal Revenue Code. Expenses related to matching employee contributions to the 401(k) plan were $4.1 million, $4.7 million, and $4.1 million in 2024, 2023, and 2022, respectively. Additionally, in 2024, 2023, and 2022 the Company provided discretionary supplemental contributions to the individual 401(k) accounts of substantially all employees. Each employee received a supplemental contribution to their account based on a uniform percentage of qualifying compensation established annually. The cost of these supplemental contributions totaled $7.0 million, $6.9 million, and $7.4 million in 2024, 2023, and 2022, respectively.

Other Operating Income, Net

Other Operating Income, Net	12 Months Ended
	Dec. 31, 2024
Other Operating Income, Net [Abstract]
Other Operating Income, Net	12. Other Operating Income, Net Other operating income, net consists of the following: Year ended December 31, 2024 2023 2022 Gain on sale of operating assets $ — $ 5 $ 36

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2024
Income Taxes [Abstract]
Income Taxes	13. Income Taxes The Company files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. With few exceptions, the Company is no longer subject to U.S. federal and state income tax examinations by tax authorities for years before 2017. The federal and state income tax provision consisted of the following: Year ended December 31, 2024 2023 2022 Current Deferred Current Deferred Current Deferred Federal $ 10,310 $ (4,190 ) $ 14,763 $ (5,285 ) $ 21,741 $ (4,694 ) State 1,607 (515 ) 1,713 (582 ) 3,779 (879 ) $ 11,917 $ (4,705 ) $ 16,476 $ (5,867 ) $ 25,520 $ (5,573 ) The effective income tax rate varied from the statutory federal income tax rate as follows: Year ended December 31, 2024 2023 2022 Statutory federal income tax rate 21.0% 21.0% 21.0% State income taxes, net of federal tax benefit 1.5 2.2 2.7 Research and development tax credits (5.9 ) (2.7 ) (4.2 ) Other 2.5 (2.5 ) (1.1 ) Effective income tax rate 19.1% 18.0% 18.4% The Company estimates that its effective tax rate in 2025 will approximate 20.3%. Significant components of the Company’s deferred tax assets and liabilities are as follows: December 31, 2024 2023 Deferred tax assets Capitalized research and development costs $ 12,566 $ 9,144 Employee compensation and benefits 2,483 2,452 Allowances for doubtful accounts and discounts 452 431 Inventories 1,831 1,635 Stock-based compensation 1,876 1,698 Other 1,537 1,608 Total deferred tax assets 20,745 16,968 Deferred tax liabilities: Depreciation 2,868 3,578 Other 1,196 1,414 Total deferred tax liabilities 4,064 4,992 Net deferred tax assets $ 16,681 $ 11,976 In 2022, the Company adopted the provisions of the Tax Cuts and Jobs Act of 2017 that relate to IRS Code Section 174. Under these provisions, research and development costs must be capitalized and amortized over five years for income tax purposes. The Company continues to expense these costs in the period incurred for financial accounting purposes. The Company made income tax payments of approximately $10.6 million, $26.0 million, and $28.7 million, during 2024, 2023, and 2022, respectively. The Company expects to realize its deferred tax assets through tax deductions against future taxable income . The Company does not believe it has included any “uncertain tax positions” in its federal income tax return or any of the state income tax returns it is currently filing. The Company has made an evaluation of the potential impact of additional state taxes being assessed by jurisdictions in which the Company does not currently consider itself liable. The Company does not anticipate that such additional taxes, if any, would result in a material change to its financial position.

Earnings Per Share

Earnings Per Share	12 Months Ended
	Dec. 31, 2024
Earnings Per Share [Abstract]
Earnings Per Share	14. Earnings Per Share Set forth below is a reconciliation of the numerator and denominator for the basic and diluted earnings per share calculations for the periods indicated: Year ended December 31, 2024 2023 2022 Numerator: Net income $ 30,563 $ 48,215 $ 88,332 Denominator: Weighted average number of common shares outstanding – Basic 17,088,205 17,676,955 17,648,850 Dilutive effect of options and restricted stock units outstanding under the Company’s employee compensation plans 181,896 134,263 144,498 Weighted average number of common shares outstanding – Diluted 17,270,101 17,811,218 17,793,348

Stock Repurchases

Stock Repurchases	12 Months Ended
	Dec. 31, 2024
Stock Repurchases [Abstract]
Stock Repurchases	15. Stock Repurchases In 2024, 2023, and 2022 the Company repurchased shares of its common stock. Details of these purchases are as follows: Period Total Average Total Number Maximum Third Quarter 2022 July 3 to July 30 — — — July 31 to August 27 — — — August 28 to October 1 2,136 $ 49.97 2,136 Fourth Quarter 2022 October 2 to October 29 — — — October 30 to November 26 2,304 $ 49.77 2,304 November 27 to December 31 — — — Fourth Quarter 2023 October 1 to October 28 — — — October 29 to November 25 179,341 $ 45.20 179,341 November 26 to December 31 84,721 $ 43.67 84,721 First Quarter 2024 January 1 to January 27 7,317 $ 43.42 7,317 January 28 to February 24 20,307 $ 42.93 20,307 February 25 to March 30 47,400 $ 42.79 47,400 Second Quarter 2024 March 31 to April 27 — — — April 28 to May 25 28,924 $ 42.92 28,924 May 26 to June 29 373,969 $ 42.27 373,969 Third Quarter 2024 June 30 to July 27 156,517 $ 41.27 156,517 July 28 to August 24 — — — August 25 to September 28 64,325 $ 40.66 64,325 Fourth Quarter 2024 September 29 to October 26 11,340 $ 40.50 11,340 October 27 to November 23 52,129 $ 39.50 52,129 November 23 to December 31 72,832 $ 34.81 72,832 Total 1,103,562 $ 42.07 1,103,562 $ 40,290,000 All of these purchases were made with cash held by the Company and no debt was incurred At December 31, 2024, approximately $40.3 million remained authorized for share repurchases.

Compensation Plans

Compensation Plans	12 Months Ended
	Dec. 31, 2024
Compensation Plans [Abstract]
Compensation Plans	16. Compensation Plans In May 2017, the Company’s shareholders approved the 2017 Stock Incentive Plan (the “2017 SIP”) under which employees, independent contractors, and non-employee directors may be granted stock options, restricted stock, deferred stock awards, and stock appreciation rights, any of which may or may not require the satisfaction of performance objectives. Vesting requirements are determined by the Compensation Committee of the Board of Directors . In June 2023, the Company’s shareholders approved the 2023 Stock Incentive Plan (the “2023 SIP”) under which employees, independent contractors, and non-employee directors may be granted stock options, restricted stock, deferred stock awards, and stock appreciation rights, any of which may or may not require the satisfaction of performance objectives. Vesting requirements are determined by the Compensation Committee of the Board of Directors. The Company reserved 1,000,000 shares for issuance under the 2023 SIP, of which 845,000 shares remain available for future grants as of December 31, 2023. Approximately 150,000 shares remaining from the 2017 SIP will be available for future grants under the terms of the 2023 SIP. Since the shareholder approval of the 2023 SIP, no additional awards have been or will be granted under the 2017 SIP. Previously granted and outstanding awards under the 2017 SIP will remain subject to the terms of the 2017 SIP. Compensation expense related to deferred stock, restricted stock, and restricted stock units is recognized based on the grant-date fair value of the Company’s common stock, using either the actual share price or an estimated value using the Monte Carlo valuation model. The total stock-based compensation cost included in the Statements of Income was $5.8 million, $6.2 million, and $5.7 million in 2024, 2023, and 2022, respectively. Deferred Stock Deferred stock awards vest based on the passage of time or the Company’s attainment of performance objectives. Upon vesting, these awards convert one-for-one to common stock. In 2024, 9,291 deferred stock awards were issued to non-employee directors that will vest in June 2025 and 11,992 deferred stock awards were issued to non-employee directors that will vest in June 2027 In 2023, 7,566 deferred stock awards were issued to non-employee directors that vested in June 2024 and 9,760 deferred stock awards were issued to non-employee directors that will vest in June 2026. In 2022, 5,953 deferred stock awards were issued to non-employee directors that vested in May 2023, 7,688 deferred stock awards were issued to non-employee directors that will vest in May 2025 and a 1,478 deferred stock award was issued to a non-employee director that will vest in June 2027. Compensation expense related to these awards is amortized ratably over the vesting period. Compensation expense related to these awards was $0.9 million in 2024, $0.9 million in 2023, and $0.8 million in 2022. At December 31, 2024, there was $1.0 million of unrecognized compensation cost related to deferred stock that is expected to be recognized over a period of three years. Restricted Stock Units The Company grants restricted stock units (RSU’s) to senior employees. Some of these RSU’s are retention awards and have only time-based vesting. Other RSU’s have a vesting “double trigger.” The vesting of these RSU’s is dependent on the achievement of corporate objectives established by the Compensation Committee of the Board of Directors, including return on net operating assets, stock performance, and the passage of time. During 2024, 153,000 restricted stock units were issued. Compensation costs related to these restricted stock units was $6.8 million, of which $1.9 million was recognized in 2024. The costs are being recognized ratably over the remaining periods required before the units vest, which range from 24 to 26 months. During 2023, 114,000 restricted stock units were issued. Compensation costs related to these restricted stock units was $6.1 million, of which $1.3 million was recognized in 2023. The costs are being recognized ratably over the remaining periods required before the units vest, which range from 24 to 26 months. During 2022, 82,000 restricted stock units were issued. Compensation costs related to these restricted stock units was $6.0 million, of which $1.7 million was recognized in 2022. The costs are being recognized ratably over the remaining periods required before the units vest, which range from 24 to 26 months. At December 31, 2024, there was $7.8 million of unrecognized compensation cost related to restricted stock units that is expected to be recognized over a period of 3.3 years.

Operating Segment Information

Operating Segment Information	12 Months Ended
	Dec. 31, 2024
Operating Segment Information [Abstract]
Operating Segment Information	17. Operating Segment Information The Company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors primarily located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. Corporate segment income relates to interest income, the sale of non-operating assets, and other non-operating activities. Corporate segment assets consist of cash and other non-operating assets. The Company evaluates performance and allocates resources, in part, based on income (loss) before taxes. The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies (see Note 1). Intersegment sales are recorded at the Company’s cost plus a fixed profit percentage. This segment structure reflects the financial information and reports used by the Company’s management, specifically its CODM, to make decisions regarding the Company’s business, including resource allocations and performance assessments, as well as the current operating focus in compliance with ASC 280, Segment Reporting. The Company’s reportable segments are not aggregated. The Company’s method for measuring performance of a reportable segment is primarily gross profit. The CODM does not review disaggregated assets by segment. The Company adopted ASU 2023-07 in January 2025. The most significant provision was the required disclosure of significant segment expenses that are regularly provided to the CODM. The Company’s CODM periodically reviews cost of goods sold by segment and treats it as a significant segment expense. Year ended December 31, 2024 2023 2022 Net Sales Firearms $ 532,608 $ 540,746 $ 593,289 Castings Unaffiliated 3,035 3,021 2,553 Intersegment 31,528 33,086 21,306 34,563 36,107 23,859 Eliminations (31,528 ) (33,086 ) (21,306 ) $ 535,643 $ 543,767 $ 595,842 Costs of Goods Sold Firearms $ 417,222 $ 407,068 $ 410,507 Castings Unaffiliated 4,006 3,080 5,250 Intersegment 31,528 33,086 21,306 35,534 36,166 26,556 Eliminations (31,528 ) (33,086 ) (21,306 ) $ 421,228 $ 410,148 $ 415,757 Gross Profit (Loss) Firearms $ 115,386 $ 133,678 $ 182,782 Castings (971 ) (59 ) (2,697 ) $ 114,415 $ 133,619 $ 180,085 Operating Income (Loss) Firearms $ 33,273 $ 52,887 $ 106,803 Castings (1,619 ) (803 ) (3,347 ) $ 31,654 $ 52,084 $ 103,456 Income (Loss) Before Income Taxes Firearms $ 34,051 $ 53,723 $ 108,609 Castings (1,616 ) (799 ) (3,338 ) Corporate 5,340 5,900 3,008 $ 37,775 $ 58,824 $ 108,279 Year ended December 31, 2024 2023 2022 Identifiable Assets Firearms $ 230,024 $ 228,699 $ 223,301 Castings 9,303 11,144 11,910 Corporate 144,707 158,974 249,552 $ 384,034 $ 398,817 $ 484,763 Goodwill Firearms $ 3,055 $ 3,055 $ 3,055 Castings 209 209 209 $ 3,264 $ 3,264 $ 3,264 Depreciation Firearms $ 19,952 $ 19,301 $ 21,992 Castings 1,154 1,814 2,452 $ 21,106 $ 21,115 $ 24,444 Capital Expenditures Firearms $ 20,488 $ 15,395 $ 26,598 Castings 333 401 1,175 $ 20,821 $ 15,796 $ 27,773 In 2024, the Company’s largest customers and the percent of firearms sales they represented were as follows: Lipsey’s - 28%; Sports South - 18%; and Davidson’s - 16%. In 2023, the Company’s largest customers and the percent of firearms sales they represented were as follows: Lipsey’s - 24%; Davidson’s - 19%; and Sports South -15%. In 2022, the Company’s largest customers and the percent of firearms sales they represented were as follows: Lipsey’s - 23%; Davidson’s - 23%; and Sports South - 21%. The Company’s assets are located entirely in the United States and domestic sales represented at least 94% of total sales in 2024, 2023, and 2022.

Quarterly Results of Operations

Quarterly Results of Operations (Unaudited)	12 Months Ended
	Dec. 31, 2024
Quarterly Results of Operations (Unaudited) [Abstract]
Quarterly Results of Operations (Unaudited)	18. Quarterly Results of Operations (Unaudited) The following is a tabulation of the unaudited quarterly results of operations for the two years ended December 31, 2024: Three Months Ended 3/30/24 6/29/24 9/28/24 12/31/24 Net Sales $ 136,820 $ 130,761 $ 122,287 $ 145,775 Gross profit 29,403 29,154 22,672 33,186 Net income 7,084 8,264 4,738 10,477 Basic earnings per share 0.41 0.48 0.28 0.63 Diluted earnings per share $ 0.40 $ 0.47 $ 0.28 $ 0.62 Three Months Ended 4/1/23 7/1/23 9/30/23 12/31/23 Net Sales $ 149,453 $ 142,804 $ 120,893 $ 130,617 Gross profit 38,486 38,148 24,728 32,257 Net income 14,350 16,185 7,431 10,249 Basic earnings per share 0.81 0.91 0.42 0.58 Diluted earnings per share $ 0.81 $ 0.91 $ 0.42 $ 0.58

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2024
Related Party Transactions [Abstract]
Related Party Transactions	19. Related Party Transactions From time to time, the Company contracts with the National Rifle Association (“NRA”) for some of its promotional and advertising activities. The Company paid the NRA $0.5 million, $0.5 million and $0.7 million in 2024, 2023, and 2022, respectively. One of the Company’s Directors also serves as a Director on the Board of the NRA. The Company is a member of the National Shooting Sports Foundation (“NSSF”), the firearm industry trade association. The Company paid the NSSF $0.4 million, $0.3 million and $0.3 million in 2024, 2023, and 2022, respectively.

Contingent Liabilities

Contingent Liabilities	12 Months Ended
	Dec. 31, 2024
Contingent Liabilities [Abstract]
Contingent Liabilities	20. Contingent Liabilities As of December 31, 2024, the Company was a defendant in eight (8) lawsuits and is aware of cert Municipal Litigation Municipal litigation generally includes those cases brought by cities or other governmental entities against firearms manufacturers, distributors and retailers seeking to recover damages allegedly arising out of the criminal misuse of firearms by third parties. There are four (4) lawsuits of this type, as follows. In City of Gary v. Smith & Wesson Corp., et al On March 15, 2024, Indiana Governor Eric Holcomb signed into law HB 1235, which reserves to the State of Indiana the right to bring an action on behalf of a political subdivision against a firearm or ammunition manufacturer, trade association, seller, or dealer, concerning certain matters. The new law also prohibits a political subdivision from bringing or maintaining such an action. Following passage of this new law, the Company and other Defendants filed a Motion for Judgment on the Pleadings on March 18, 2024. On August 12, 2024, the Court denied Defendants’ motion. The Court granted Defendants’ subsequent request to certify the Order for appeal. On October 2, 2024, Defendants filed a motion with the Indiana Court of Appeals to accept jurisdiction over the interlocutory appeal, which was granted over Plaintiff’s objection on November 1, 2024. On October 16, 2024, the trial court entered an Order staying all proceedings pending the interlocutory appeal. Briefing of the appeal is underway. Estados Unidos Mexicanos v. Smith & Wesson Brands, Inc., et al. On November 22, 2021, Defendants jointly filed a motion to dismiss the Complaint, which was granted on September 30, 2022. Several defendants, including the Company, also filed Rule 12(b)(2) motions to dismiss for lack of personal jurisdiction, which the Court declined to rule on in light of its dismissal. Plaintiffs appealed the dismissal to the First Circuit Court of Appeals and, on January 22, 2024, the Court of Appeals reversed the District Court’s dismissal and remanded the case for further proceedings. The Defendants filed a Petition for Writ of Certiorari seeking review by the United States Supreme Court while the case moved forward at the District Court. On June 17, 2024, the District Court heard argument on the pending Rule 12(b)(2) motions to dismiss. On August 7, 2024, the Court granted the motions, dismissing the Company and some of the other Defendants from the case, but has not yet entered judgement in favor of these Defendants. Because judgment has not entered in favor of the Company, the 30-day period in which Plaintiff may appeal the Court’s August 7, 2024 ruling has not yet begun to run. Subsequently, the Supreme Court granted the Defendants’ Petition for Writ of Certiorari. Oral argument at the Supreme Court is scheduled for March 4, 2025. On December 20, 2022, the City of Buffalo, New York filed a lawsuit captioned The City of Buffalo v. Smith & Wesson Brands, Inc., et al. On December 21, 2022, the City of Rochester, New York filed a lawsuit captioned The City of Rochester v. Smith & Wesson Brands, Inc., et al. Buffalo Defendants moved to consolidate the Buffalo Rochester National Shooting Sports Foundation, Inc. et al. v. James Breach of Contract The Company is a defendant in Jones v. Sturm, Ruger & Co., The Company moved to dismiss the Amended Complaint, and on March 27, 2024, the Court dismissed Plaintiffs’ negligence and unjust enrichment claims against the Company. The Court denied the motion with respect to Plaintiffs’ breach of contract claim, concluding that development of additional information is required to assess the applicability of the limitation of liability clause contained in the Company’s terms and conditions of use. The case is proceeding accordingly. Unfair Trade Practices Estate of Suzanne Fountain v. Sturm, Ruger & Co., Inc., Ahmad Al Aliwi Al-Issa. The Complaint alleged that the Company’s advertising and marketing of the Ruger AR-556 pistol violate the Connecticut Unfair Trade Practices Act and were a substantial factor in bringing about the wrongful death of Suzanne Fountain. Estate of Neven Stanisic et al. v. Sturm, Ruger & Co., Inc., Estate of Suzanne Fountain Ahmad Al Aliwi Al-Issa and Plaintiffs alleged that the Company’s advertising and marketing of the Ruger AR-556 pistol violate the Connecticut Unfair Trade Practices Act and were a substantial factor in causing the wrongful death of Plaintiffs’ decedents. The Fountain Stanisic The matter was timely removed to the U.S. District Court for the District of Connecticut based upon the new allegations and federal question jurisdiction. Plaintiffs moved to remand the case to state court and, following briefing and oral argument, the matter was remanded on April 25, 2024. On June 12, 2024, Ruger filed Motions to Dismiss the Connecticut state court cases based upon the doctrine of forum non conveniens Trademark Litigation On March 12, 2024, FN Herstal, et al. v. Sturm, Ruger & Company, Inc. he Complaint alleges that the Company’s use of the initialism “SFAR” in connection with the marketing of its Small Frame Autoloading Rifle infringes the Plaintiffs’ SCAR trademark. The Complaint alleges violations of the Lanham Act and the North Carolina Unfair and Deceptive Trade Practices Act, as well as trademark infringement under North Carolina common law. The Company believes that the allegations are meritless and is defending the action accordingly. Summary of Claimed Damages and Explanation of Product Liability Accruals Punitive damages, as well as compensatory damages, are demanded in certain of the lawsuits and claims. In many instances, the plaintiff does not seek a specified amount of money, though aggregate amounts ultimately sought may exceed product liability accruals and applicable insurance coverage. For product liability claims made between July 10, 2000 and August 31, 2024, insurance coverage was provided on an annual basis for losses exceeding $5 million per claim, with an aggregate maximum loss of $10 million annually, except for certain claims brought by governments or municipalities, which are excluded from coverage. Insurance coverage was not renewed with incumbent carriers effective September 1, 2024. Rather, the Company established a wholly-owned captive insurance company for claims made on or after September 1, 2024. Company management monitors the status of known claims and the product liability accrual, which includes amounts for asserted and unasserted claims. While it is not possible to forecast the outcome of litigation or the timing of costs, in the opinion of management, after consultation with special and corporate counsel, it is not probable and is unlikely that litigation, including punitive damage claims, will have a material adverse effect on the financial position of the Company, but may have a material impact on the Company’s financial results for a particular period. Product liability claim payments are made when appropriate if, as, and when claimants and the Company reach agreement upon an amount to finally resolve all claims. Legal costs are paid as the lawsuits and claims develop, the timing of which may vary greatly from case to case. A time schedule cannot be determined in advance with any reliability concerning when payments will be made in any given case. Provision is made for product liability claims based upon many factors related to the severity of the alleged injury and potential liability exposure, based upon prior claim experience. Because the Company's experience in defending these lawsuits and claims is that unfavorable outcomes are typically not probable or estimable, only in rare cases is an accrual established for such costs. In most cases, an accrual is established only for estimated legal defense costs. Product liability accruals are periodically reviewed to reflect then-current estimates of possible liabilities and expenses incurred to date and reasonably anticipated in the future. Threatened product liability claims are reflected in the Company's product liability accrual on the same basis as actual claims; i.e. Often, a Complaint does not specify the amount of damages being sought and range of reasonably possible losses relating to unfavorable outcomes cannot be made. The dollar amount of damages claimed at December 31, 2024, December 31, 2023, and December 31, 2022 was de minimis of the likelihood or reasonable probability of any or all of this amount being awarded to claimants) as a result of adverse judgments that are sustained on appeal. During 2024, one (1) trademark lawsuit was filed against the Company, one (1) negligence lawsuit was resolved, and one (1) traditional product liability lawsuit was resolved. One (1) municipal lawsuit was dismissed, however the time period in which to file an appeal has been stayed by the Court and the Company considers this matter still open. As of December 31, 2024, the Company was a defendant in eight (8) lawsuits involving its products, including four (4) municipal lawsuits, two (2) lawsuits based upon unfair trade practices, one (1) breach of contract, and one (1) trademark litigation. During 2023, one (1) traditional product liability lawsuit was filed against the Company and one (1) was resolved. As of December 31, 2023, the Company was a defendant in seven (7) lawsuits involving its products, including one (1) traditional product liability lawsuit, four (4) municipal lawsuits and two (2) lawsuits based upon alleged unfair trade practices. The Company was also a defendant in two (2) negligence lawsuits. During 2022, no traditional product liability lawsuits were filed against the Company and one (1) was resolved. As of December 31, 2022, the Company was a defendant five lawsuits involving its products, including one (1) traditional product liability lawsuit and four (4) municipal lawsuits. The Company also was a defendant in three (3) negligence lawsuits though, as discussed above, that number has since been reduced to two (2) lawsuits with the consolidation of the Jones Copeland The Company’s product liability expense was $0.7 million in 2024, $1.5 million in 2023, $1.3 million in 2022. This expense includes the cost of outside legal fees, and other expenses incurred in the management and defense of product liability matters. A roll-forward of the product liability reserve and detail of product liability expense for the three years ended December 31, 2024 follows: Balance Sheet Roll-forward for Product Liability Reserve Cash Payments Balance ) Accrued Legal Fees Settlements Balance 2022 $ 892 (417 ) (167 ) — $ 308 2023 $ 308 500 (129 ) — $ 679 2024 $ 679 67 (254 ) — $ 492 Income Statement Detail for Product Liability Expense Accrued Insurance Total 2022 $ (417 ) 1,524 $ 1,107 2023 $ 500 1,226 $ 1,726 2024 $ 67 908 $ 975 Notes (a) The beginning and ending liability balances represent accrued legal fees only. Settlements and administrative costs are expensed as incurred. Only in rare instances is an accrual established for settlements. (b) The expense accrued in the liability is for legal fees only. In 2022, the costs incurred related to cases that were settled or dismissed were less than the amounts accrued for these cases in prior years. (c) Legal fees represent payments to outside counsel related to product liability matters. (d) Settlements represent payments made to plaintiffs or allegedly injured parties in exchange for a full and complete release of liability. (e) Insurance expense represents the cost of insurance premiums. There were no insurance recoveries during any of the above years.

Financial Instruments

Financial Instruments	12 Months Ended
	Dec. 31, 2024
Financial Instruments [Abstract]
Financial Instruments	21. Financial Instruments The Company does not hold or issue financial instruments for trading or hedging purposes, nor does it hold interest rate, leveraged, or other types of derivative financial instruments. Fair values of accounts receivable, accounts payable, accrued expenses and income taxes payable reflected in the December 31, 2024 and 2023 balance sheets approximate carrying values at those dates.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	22. Subsequent Events On February 14, 2025, the Company’s Board of Directors authorized a dividend of 24¢ per share to shareholders of record on March 14, 2025. On January 17, 2025, the Company announced the appointment of Mr. Todd W. Seyfert as its next President & Chief Executive Officer, effective March 1, 2025. Mr. Christopher J. Killoy will step down as President & Chief Executive Officer on that date and then serve as a Special Advisor through his planned retirement from the Company in May 2025. Mr. Kevin B. Reid, Sr. will step down as Vice President, General Counsel, and Corporate Secretary on June 30, 2025 and then serve as Senior Counsel to the Company until his planned retirement from the Company on June 30, 2026. The Company’s management has evaluated transactions occurring subsequent to December 31, 2024 and determined that there were no other events or transactions during that period that would have a material impact on the Company’s results of operations or financial position.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2024	Sep. 28, 2024	Jun. 29, 2024	Mar. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Jul. 01, 2023	Apr. 01, 2023	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Pay vs Performance Disclosure
Net Income (Loss)	$ 10,477	$ 4,738	$ 8,264	$ 7,084	$ 10,249	$ 7,431	$ 16,185	$ 14,350	$ 30,563	$ 48,215	$ 88,332

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2024 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	Rule 10b5-1 Trading Plans The adoption or termination of contracts, instructions or written plans for the purchase and sale of the Company’s securities by the Company’s Section 16 officers or directors for the three months ended December 31, 2024, each of which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (“Rule 10b5-1 Plan”), were as follows: Name Title Action Date Expiration Aggregate # of John A. Cosentino, Jr. (1) Director Adoption of Rule 10b5-1 Plan November 14, 2024 November 14, 2025 5,000 (1) John A. Cosentino, Jr., a director of the Company, entered into a Rule 10b5-1 Plan on November 14, 2024. Mr. Cosentino’s Rule 10b5-1 Plan provides for the potential sale of up to 5,000 shares of the Company’s common stock. The Rule 10b5-1 Plan expires on November 14, 2025, or upon the earlier completion of all authorized transactions under such Rule 10b5-1 Plan. None of the Company’s directors or Section 16 officers adopted or terminated a “non-Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K during the three months ended December 31, 2024.
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
John A. Cosentino, Jr [Member]
Trading Arrangements, by Individual
Name	John A. Cosentino, Jr.	[1]
Title	Director	[1]
Rule 10b5-1 Arrangement Adopted	true	[1]
Adoption Date	November 14, 2024	[1]
Expiration Date	November 14, 2025	[1]
Aggregate Available	5,000	[1]
[1]John A. Cosentino, Jr., a director of the Company, entered into a Rule 10b5-1 Plan on November 14, 2024. Mr. Cosentino’s Rule 10b5-1 Plan provides for the potential sale of up to 5,000 shares of the Company’s common stock. The Rule 10b5-1 Plan expires on November 14, 2025, or upon the earlier completion of all authorized transactions under such Rule 10b5-1 Plan.

Cybersecurity Risk Management a

Cybersecurity Risk Management and Strategy Disclosure	12 Months Ended
	Dec. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Line Items]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]	Risk management and strategy The Company has processes for assessing, identifying, and managing material risks from cybersecurity threats. These processes are integrated into the Company’s overall risk management systems, as overseen by the Company’s Board of Directors, primarily through its Risk Oversight Committee. These processes also include overseeing and identifying risks from cybersecurity threats associated with the use of third-party service providers. The Company conducts security assessments of certain third-party providers before engagement and has established monitoring procedures in its effort to mitigate risks related to data breaches or other security incidents originating from third parties. The Company from time to time engages third-party consultants, legal advisors, and audit firms in evaluating and testing the Company’s risk management systems and assessing and remediating certain potential cybersecurity incidents as appropriate. The Company has an Information Security Program (“Program”) to protect personal and proprietary information in compliance with applicable federal and state requirements. The Program is designed to: ● Ensure the security and confidentiality of employee and customer personal information and Company proprietary information; ● Protect against anticipated threats or hazards to the security or integrity of such information; and ● Protect against unauthorized access to, use of, or transfer of such information in a manner that could harm or inconvenience the Company, employees or customers. For more information about these risks, see the risk factor titled “The Company relies on its information and communications systems in its operations. Security breaches and other disruptions could adversely affect its business and results of operations” under Item 1A.
Cybersecurity Risk Management Processes Integrated [Text Block]	These processes are integrated into the Company’s overall risk management systems, as overseen by the Company’s Board of Directors, primarily through its Risk Oversight Committee.
Cybersecurity Risk Management Processes Integrated [Flag]	true
Cybersecurity Risk Management Third Party Engaged [Flag]	true
Cybersecurity Risk Board of Directors Oversight [Text Block]	Governance The Company’s Board of Directors has assigned oversight of cybersecurity risk management to the Risk Oversight Committee. The Risk Oversight Committee regularly receives reports from management, including senior information technology (“IT”) leadership, and third parties on cybersecurity matters. In addition, the Company’s full Board of Directors receives reports addressing cybersecurity as part of the Company’s overall enterprise risk management program and to the extent cybersecurity matters are addressed in regular business updates. Senior IT leaders are responsible for developing appropriate cybersecurity programs, including as may be required by applicable law or regulation. These individuals’ expertise in IT and cybersecurity generally has been gained from a combination of education, including relevant degrees and/or certifications, and work experience. They are informed by their respective cybersecurity teams about, and monitor, the prevention, detection, mitigation and remediation of cybersecurity incidents as part of the cybersecurity programs described above. Information regarding cybersecurity risks may be elevated by IT leadership through a variety of channels, including discussions between or among key leaders and Company management and reports to the Company’s Board of Directors and/or certain Board committees.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]	The Company’s Board of Directors has assigned oversight of cybersecurity risk management to the Risk Oversight Committee.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]	The Risk Oversight Committee regularly receives reports from management, including senior information technology (“IT”) leadership, and third parties on cybersecurity matters.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]	These individuals’ expertise in IT and cybersecurity generally has been gained from a combination of education, including relevant degrees and/or certifications, and work experience.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]	Information regarding cybersecurity risks may be elevated by IT leadership through a variety of channels, including discussions between or among key leaders and Company management and reports to the Company’s Board of Directors and/or certain Board committees.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]	true

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	12 Months Ended
	Dec. 31, 2024
Significant Accounting Policies [Abstract]
Organization	Organization Sturm, Ruger & Company, Inc. (the “Company”) is principally engaged in the design, manufacture, and sale of firearms to domestic customers. Approximately 99% of sales were from firearms. Export sales represented approximately 5% of firearms sales. The Company’s design and manufacturing operations are located in the United States and almost all product content is domestic. The Company’s firearms are sold through a select number of independent wholesale distributors principally to the commercial sporting market. The Company manufactures investment castings made from steel alloys and metal injection molding (“MIM”) parts for internal use in its firearms and utilizes available capacity to manufacture and sell investment castings and MIM parts to unaffiliated, third-party customers. Castings were less than 1% of the Company’s total sales for the year ended December 31, 2024.
Preparation of Financial Statements	Preparation of Financial Statements The Company follows United States generally accepted accounting principles (“GAAP”). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. The significant accounting policies described below, together with the notes that follow, are an integral part of the consolidated financial statements.
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated.
Revenue Recognition	Revenue Recognition The Company recognizes revenue in accordance with the provisions of Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (“ASC 606”), which became effective January 1, 2018. Substantially all product sales are sold FOB (free on board) shipping point. Customary payment terms are 2% 30 days, net 40 days. Generally, all performance obligations are satisfied when product is shipped and the customer takes ownership and assumes the risk of loss. In some instances, sales include multiple performance obligations. The most common of these instances relates to sales promotion programs under which downstream customers are entitled to receive no charge products based on their purchases of certain of the Company’s products from the independent distributors. The fulfillment of these no charge products is the Company’s responsibility. In such instances, the Company allocates the revenue of the promotional sales based on the estimated level of participation in the sales promotional program and the timing of the shipment of all of the firearms included in the promotional program, including the no charge firearms. Revenue is recognized proportionally as each performance obligation is satisfied, based on the relative customary price of each product. Customary prices are generally determined based on the prices charged to the independent distributors. The net change in contract liabilities for a given period is reported as an increase or decrease to sales. The Company accounts for cash sales discounts as a reduction in sales. Amounts billed to customers for shipping and handling fees are included in net sales and costs incurred by the Company for the delivery of goods are classified as selling expenses. Federal excise taxes are excluded from net sales.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers interest-bearing deposits with financial institutions with remaining maturities of three months or less at the time of acquisition to be cash equivalents.
Fair Value Measurements of Short-term Investments	Fair Value Measurements of Short-term Investments Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the principal or most advantageous market at the measurement date. Fair value is established according to a hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below: Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs. Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data. Level 3: Unobservable inputs are used when little or no market data is available. Level 3 inputs are given the lowest priority in the fair value hierarchy. The asset or liability’s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the use of unobservable inputs. As of December 31, 2024, the Company’s short-term investments consist of U.S. Treasury instruments (Level 1), maturing within one year, and . For the bank-managed money market fund, t . Such securities are classified as held to maturity, since the Company has the intent and ability to do so, and are carried at cost plus accrued interest, which approximates fair value. The fair value of inventory acquired as part of business combination is based on a third-party valuation utilizing the comparable sales method which is based on Level 2 and Level 3 inputs. The fair value of property, plant and equipment acquired as part of business combination is based on a third-party valuation utilizing the indirect method of cost approach, which is based on Level 2 and Level 3 inputs. The fair value of patents acquired as part of business combination is based on a third-party valuation utilizing the replacement cost method, which is based on Level 2 and Level 3 inputs. The fair value of the remaining intangible assets as part of business combination are based on a third-party valuation utilizing discounted cash flow methods that involves inputs, which are not observable in the market (Level 3).
Accounts Receivable	Accounts Receivable The Company establishes an allowance for doubtful accounts based on the creditworthiness of its customers and historical experience. While the Company uses the best information available to make its evaluation, future adjustments to the allowance for doubtful accounts may be necessary if there are significant changes in economic and industry conditions or any other factors considered in the Company’s evaluation. Bad debt expense has been immaterial during each of the last three years. The Company mitigates its credit risk by maintaining credit insurance on most of its significant customers.
Inventories	Inventories Substantially all of the Company’s inventories are valued at the lower of cost, principally determined by the last-in, first-out (LIFO) method, or net realizable value. Elements of cost in inventories include raw materials, direct labor and manufacturing overhead.
Property, Plant and Equipment	Property, Plant and Equipment Property, plant and equipment are carried at cost. Depreciation is computed over useful lives using the straight-line and declining balance methods predominately over 15 years for buildings, 7 years for machinery and equipment and 3 years for tools and dies. When assets are retired, sold or otherwise disposed of, their gross carrying values and related accumulated depreciation are removed from the accounts and a gain or loss on such disposals is recognized when appropriate. Maintenance and repairs are charged to operations; replacements and improvements are capitalized.
Long-lived Assets	Long-lived Assets The Company evaluates the carrying value of long-lived assets to be held and used when events or changes in circumstances indicate the carrying value may not be recoverable. In performing this review, the carrying value of the assets is compared to the projected undiscounted cash flows to be generated from the assets. If the sum of the undiscounted expected future cash flows is less than the carrying value of the assets, the assets are considered to be impaired. Impairment losses are measured as the amount by which the carrying value of the assets exceeds their fair value. The Company bases fair value of the assets on quoted market prices if available or, if not available, quoted market prices of similar assets. Where quoted market prices are not available, the Company estimates fair value using the estimated future cash flows generated by the assets discounted at a rate commensurate with the risks associated with the recovery of the assets. As of December 31, 2024, the Company does not believe there are any indications of impairment related to long-lived assets.
Goodwill	Goodwill The Company’s goodwill represents the excess of the purchase price of business combinations over the fair value of the net assets acquired. We assess goodwill for impairment on an annual basis during the fourth quarter of each year, and between annual tests whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment exists by the amount the fair value of a reporting unit to which goodwill has been allocated is less than their respective carrying values. The impairment for goodwill is limited to the total amount of goodwill allocated to the reporting unit. Goodwill impairment testing requires significant judgment and management estimates, including, but not limited to, the determination of (i) the number of reporting units, (ii) the goodwill and other assets and liabilities to be allocated to the reporting units and (iii) the fair values of the reporting units. The estimates and assumptions described above, along with other factors such as discount rates, will significantly affect the outcome of the impairment tests and the amounts of any resulting impairment losses. As of December 31, 2024, the Company does not believe there are any indications of impairment related to goodwill.
Income Taxes	Income Taxes Income taxes are accounted for using the asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences of “temporary differences” by applying enacted statutory rates applicable to future years to temporary differences between the financial statement carrying amounts and the tax basis of the Company’s assets and liabilities.
Product Liability	Product Liability The Company provides for product liability claims including estimated legal costs to be incurred defending such claims. The provision for product liability claims is charged to cost of products sold.
Advertising Costs	Advertising Costs The Company includes advertising costs in selling expenses and these costs are expensed as incurred. Advertising costs for 2024, 2023, and 2022, were $3.4 million, $3.1 million, and $2.4 million, respectively.
Shipping Costs	Shipping Costs Costs incurred related to the shipment of products are included in selling expense. Such costs totaled $4.3 million, $4.4 million, and $4.7 million in 2024, 2023, and 2022, respectively.
Research and Development	Research and Development In 2024, 2023, and 2022, the Company spent approximately $8.2 million, $9.8 million, and $9.6 million, respectively, on research and development activities relating to new products and the improvement of existing products. These costs are included in costs of products sold and are expensed as incurred. These costs are capitalized for tax purposes under the provisions of the Tax Cuts and Jobs Act of 2017 that relate to IRS Code Section 174, as discussed in Note 13.
Earnings per Share	Earnings per Share Basic earnings per share is based upon the weighted-average number of shares of common stock outstanding during the year. Diluted earnings per share reflect the impact of restricted stock units and deferred stock outstanding using the treasury stock method.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In November of 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” The updated accounting guidance requires enhanced reportable segment disclosures, primarily related to significant segment expenses which are regularly provided to the chief operating decision maker. The guidance is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. The Company adopted ASU 2023-07, beginning with the current filing. The adoption of the new guidance required additional disclosures, but did not have a material impact to the Company. Refer to Note 17, Operating Segment Information, for the updated presentation. In December of 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” The updated accounting guidance requires expanded income tax disclosures, including the disaggregation of existing disclosures related to the effective tax rate reconciliation and income taxes paid. The guidance is effective for fiscal years beginning after December 15, 2024. Prospective application is required, with retrospective application permitted. The Company is currently evaluating the effect the updated guidance will have on its financial statement disclosures. In November 2024, the FASB issued ASU No. 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures,” which requires additional disclosure of certain costs and expenses within the notes to the financial statements. The updated standard is effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods within annual reporting periods beginning after December 15, 2027. The requirements will be applied prospectively with the option for retrospective application. Early adoption is permitted. The Company is currently evaluating the effect the updated guidance will have on its financial statement disclosures.

Revenue Recognition and Contr_2

Revenue Recognition and Contracts with Customers (Tables)	12 Months Ended
	Dec. 31, 2024
Revenue Recognition and Contracts with Customers [Abstract]
Schedule of Revenue Recognized	The impact of ASC 60 6 on revenue recognized during the years ended December 31, 2024, December 31, 2023, and 2024 2023 2022 Contract liabilities with customers at January 1, $ 149 $ 1,031 $ — Revenue recognized (149 ) (4,084 ) — Revenue deferred — 3,202 1,031 Contract liabilities with customers at December 31, $ — $ 149 $ 1,031

Trade Receivables, Net (Tables)

Trade Receivables, Net (Tables)	12 Months Ended
	Dec. 31, 2024
Trade Receivables, Net [Abstract]
Schedule of Trade Receivables	Trade receivables consist of the following: December 31, 2024 2023 Trade receivables $ 68,855 $ 61,428 Allowance for doubtful accounts (400 ) (400 ) Allowance for discounts (1,310 ) (1,164 ) $ 67,145 $ 59,864

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2024
Inventories [Abstract]
Schedule of Inventories	Inventories consist of the following: December 31, 2024 2023 Inventory at FIFO Finished goods $ 26,022 $ 30,989 Materials and products in process 123,395 119,203 Gross inventories 149,417 150,192 Less: LIFO reserve (66,398 ) (64,262 ) Less: excess and obsolescence reserve (6,533 ) (6,120 ) Net inventories $ 76,486 $ 79,810

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	12 Months Ended
	Dec. 31, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	Property, plant and equipment consist of the following: December 31, 2024 2023 Land and improvements $ 2,826 $ 2,826 Buildings and improvements 76,153 74,650 Machinery and equipment 333,365 322,730 Dies and tools 65,278 62,191 Property, plant and equipment 477,622 462,397 Less allowances for depreciation (406,373 ) (390,863 ) Net property, plant and equipment $ 71,249 $ 71,534

Other Assets (Tables)

Other Assets (Tables)	12 Months Ended
	Dec. 31, 2024
Other Assets [Abstract]
Schedule of Other Assets	Other assets consist of the following: December 31, 2024 2023 Patents, at cost $ 10,339 $ 10,280 Deposits on capital items 18,443 23,045 Marlin trade name, at cost 7,800 7,800 Accumulated amortization (8,008 ) (7,171 ) Other 9,173 9,958 $ 37,747 $ 43,912

Leased Assets (Tables)

Leased Assets (Tables)	12 Months Ended
	Dec. 31, 2024
Leased Assets [Abstract]
Schedule of Right-of-Use Assets and Related Lease Liabilities	The Company uses the effective interest method to record right-of-use assets equal to the present value of the contractual liability for future lease payments. The table below presents the right-of-use assets and related lease liabilities recognized on the condensed consolidated balance sheet as of December 31, 2024: Balance Sheet Line December 31, December 31, Right-of-use assets Other assets $ 2,345 $ 2,781 Operating lease liabilities Current portion Trade accounts payable and accrued expenses $ 598 $ 611 Noncurrent portion Lease liabilities 1,747 2,170 Total operating lease liabilities $ 2,345 $ 2,781 Year Ended December 31, December 31, Cash paid for amounts included in the measurement of lease liabilities $ 796 $ 796 Cash amounts paid for short-term leases $ 449 $ 565 Right-of-use assets obtained in exchange for lease liabilities $ — $ — Weighted average remaining lease term (years) 7.7 7.9 Weighted average discount rate 8.0% 5.0%
Schedule of Operating Lease Liabilities Future Minimum Lease Payments	The following table reconciles the undiscounted future minimum lease payments to the total operating lease liabilities recognized on the condensed consolidated balance sheet as of December 31, 2024: 2025 $ 765 2026 771 2027 295 2028 160 2029 160 Thereafter 800 Total undiscounted future minimum lease payments 2,951 Less: Difference between undiscounted lease payments & the present value of future lease payments (606 ) Total operating lease liabilities $ 2,345

Trade Accounts Payable and Ac_2

Trade Accounts Payable and Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2024
Trade Accounts Payable and Accrued Expenses [Abstract]
Schedule of Trade Accounts Payable and Accrued Expenses	Trade accounts payable and accrued expenses consist of the following: December 31, 2024 2023 Trade accounts payable $ 13,170 $ 11,100 Federal excise taxes payable 13,192 11,954 Accrued other 9,388 8,654 $ 35,750 $ 31,708

Other Operating Income, Net (Ta

Other Operating Income, Net (Tables)	12 Months Ended
	Dec. 31, 2024
Other Operating Income, Net [Abstract]
Schedule of Other Operating Income, Net	Other operating income, net consists of the following: Year ended December 31, 2024 2023 2022 Gain on sale of operating assets $ — $ 5 $ 36

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2024
Income Taxes [Abstract]
Schedule of Federal and State Income Tax Provision	The federal and state income tax provision consisted of the following: Year ended December 31, 2024 2023 2022 Current Deferred Current Deferred Current Deferred Federal $ 10,310 $ (4,190 ) $ 14,763 $ (5,285 ) $ 21,741 $ (4,694 ) State 1,607 (515 ) 1,713 (582 ) 3,779 (879 ) $ 11,917 $ (4,705 ) $ 16,476 $ (5,867 ) $ 25,520 $ (5,573 )
Schedule of Effective Income Tax Rate Reconciliation	The effective income tax rate varied from the statutory federal income tax rate as follows: Year ended December 31, 2024 2023 2022 Statutory federal income tax rate 21.0% 21.0% 21.0% State income taxes, net of federal tax benefit 1.5 2.2 2.7 Research and development tax credits (5.9 ) (2.7 ) (4.2 ) Other 2.5 (2.5 ) (1.1 ) Effective income tax rate 19.1% 18.0% 18.4%
Schedule of Deferred Tax Assets and Liabilities	Significant components of the Company’s deferred tax assets and liabilities are as follows: December 31, 2024 2023 Deferred tax assets Capitalized research and development costs $ 12,566 $ 9,144 Employee compensation and benefits 2,483 2,452 Allowances for doubtful accounts and discounts 452 431 Inventories 1,831 1,635 Stock-based compensation 1,876 1,698 Other 1,537 1,608 Total deferred tax assets 20,745 16,968 Deferred tax liabilities: Depreciation 2,868 3,578 Other 1,196 1,414 Total deferred tax liabilities 4,064 4,992 Net deferred tax assets $ 16,681 $ 11,976

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
	Dec. 31, 2024
Earnings Per Share [Abstract]
Schedule of a Reconciliation of the Numerator and Denominator for the Basic and Diluted Earnings Per Share	Set forth below is a reconciliation of the numerator and denominator for the basic and diluted earnings per share calculations for the periods indicated: Year ended December 31, 2024 2023 2022 Numerator: Net income $ 30,563 $ 48,215 $ 88,332 Denominator: Weighted average number of common shares outstanding – Basic 17,088,205 17,676,955 17,648,850 Dilutive effect of options and restricted stock units outstanding under the Company’s employee compensation plans 181,896 134,263 144,498 Weighted average number of common shares outstanding – Diluted 17,270,101 17,811,218 17,793,348

Stock Repurchases (Tables)

Stock Repurchases (Tables)	12 Months Ended
	Dec. 31, 2024
Stock Repurchases [Abstract]
Schedule of Repurchased Shares of its Common Stock	In 2024, 2023, and 2022 the Company repurchased shares of its common stock. Details of these purchases are as follows: Period Total Average Total Number Maximum Third Quarter 2022 July 3 to July 30 — — — July 31 to August 27 — — — August 28 to October 1 2,136 $ 49.97 2,136 Fourth Quarter 2022 October 2 to October 29 — — — October 30 to November 26 2,304 $ 49.77 2,304 November 27 to December 31 — — — Fourth Quarter 2023 October 1 to October 28 — — — October 29 to November 25 179,341 $ 45.20 179,341 November 26 to December 31 84,721 $ 43.67 84,721 First Quarter 2024 January 1 to January 27 7,317 $ 43.42 7,317 January 28 to February 24 20,307 $ 42.93 20,307 February 25 to March 30 47,400 $ 42.79 47,400 Second Quarter 2024 March 31 to April 27 — — — April 28 to May 25 28,924 $ 42.92 28,924 May 26 to June 29 373,969 $ 42.27 373,969 Third Quarter 2024 June 30 to July 27 156,517 $ 41.27 156,517 July 28 to August 24 — — — August 25 to September 28 64,325 $ 40.66 64,325 Fourth Quarter 2024 September 29 to October 26 11,340 $ 40.50 11,340 October 27 to November 23 52,129 $ 39.50 52,129 November 23 to December 31 72,832 $ 34.81 72,832 Total 1,103,562 $ 42.07 1,103,562 $ 40,290,000

Operating Segment Information (

Operating Segment Information (Tables)	12 Months Ended
	Dec. 31, 2024
Operating Segment Information [Abstract]
Schedule of Operating Segment Financial Information	The Company’s CODM periodically reviews cost of goods sold by segment and treats it as a significant segment expense. Year ended December 31, 2024 2023 2022 Net Sales Firearms $ 532,608 $ 540,746 $ 593,289 Castings Unaffiliated 3,035 3,021 2,553 Intersegment 31,528 33,086 21,306 34,563 36,107 23,859 Eliminations (31,528 ) (33,086 ) (21,306 ) $ 535,643 $ 543,767 $ 595,842 Costs of Goods Sold Firearms $ 417,222 $ 407,068 $ 410,507 Castings Unaffiliated 4,006 3,080 5,250 Intersegment 31,528 33,086 21,306 35,534 36,166 26,556 Eliminations (31,528 ) (33,086 ) (21,306 ) $ 421,228 $ 410,148 $ 415,757 Gross Profit (Loss) Firearms $ 115,386 $ 133,678 $ 182,782 Castings (971 ) (59 ) (2,697 ) $ 114,415 $ 133,619 $ 180,085 Operating Income (Loss) Firearms $ 33,273 $ 52,887 $ 106,803 Castings (1,619 ) (803 ) (3,347 ) $ 31,654 $ 52,084 $ 103,456 Income (Loss) Before Income Taxes Firearms $ 34,051 $ 53,723 $ 108,609 Castings (1,616 ) (799 ) (3,338 ) Corporate 5,340 5,900 3,008 $ 37,775 $ 58,824 $ 108,279 Year ended December 31, 2024 2023 2022 Identifiable Assets Firearms $ 230,024 $ 228,699 $ 223,301 Castings 9,303 11,144 11,910 Corporate 144,707 158,974 249,552 $ 384,034 $ 398,817 $ 484,763 Goodwill Firearms $ 3,055 $ 3,055 $ 3,055 Castings 209 209 209 $ 3,264 $ 3,264 $ 3,264 Depreciation Firearms $ 19,952 $ 19,301 $ 21,992 Castings 1,154 1,814 2,452 $ 21,106 $ 21,115 $ 24,444 Capital Expenditures Firearms $ 20,488 $ 15,395 $ 26,598 Castings 333 401 1,175 $ 20,821 $ 15,796 $ 27,773

Quarterly Results of Operatio_2

Quarterly Results of Operations (Unaudited) (Tables)	12 Months Ended
	Dec. 31, 2024
Quarterly Results of Operations (Unaudited) [Abstract]
Schedule of Quarterly Financial Information	The following is a tabulation of the unaudited quarterly results of operations for the two years ended December 31, 2024: Three Months Ended 3/30/24 6/29/24 9/28/24 12/31/24 Net Sales $ 136,820 $ 130,761 $ 122,287 $ 145,775 Gross profit 29,403 29,154 22,672 33,186 Net income 7,084 8,264 4,738 10,477 Basic earnings per share 0.41 0.48 0.28 0.63 Diluted earnings per share $ 0.40 $ 0.47 $ 0.28 $ 0.62 Three Months Ended 4/1/23 7/1/23 9/30/23 12/31/23 Net Sales $ 149,453 $ 142,804 $ 120,893 $ 130,617 Gross profit 38,486 38,148 24,728 32,257 Net income 14,350 16,185 7,431 10,249 Basic earnings per share 0.81 0.91 0.42 0.58 Diluted earnings per share $ 0.81 $ 0.91 $ 0.42 $ 0.58

Contingent Liabilities (Tables)

Contingent Liabilities (Tables)	12 Months Ended
	Dec. 31, 2024
Contingent Liabilities [Abstract]
Schedule of Roll-forward for Product Liability Reserve	Balance Sheet Roll-forward for Product Liability Reserve Cash Payments Balance ) Accrued Legal Fees Settlements Balance 2022 $ 892 (417 ) (167 ) — $ 308 2023 $ 308 500 (129 ) — $ 679 2024 $ 679 67 (254 ) — $ 492 (a) The beginning and ending liability balances represent accrued legal fees only. Settlements and administrative costs are expensed as incurred. Only in rare instances is an accrual established for settlements. (b) The expense accrued in the liability is for legal fees only. In 2022, the costs incurred related to cases that were settled or dismissed were less than the amounts accrued for these cases in prior years. (c) Legal fees represent payments to outside counsel related to product liability matters. (d) Settlements represent payments made to plaintiffs or allegedly injured parties in exchange for a full and complete release of liability.
Schedule of Product Liability Expense	Income Statement Detail for Product Liability Expense Accrued Insurance Total 2022 $ (417 ) 1,524 $ 1,107 2023 $ 500 1,226 $ 1,726 2024 $ 67 908 $ 975 (b) The expense accrued in the liability is for legal fees only. In 2022, the costs incurred related to cases that were settled or dismissed were less than the amounts accrued for these cases in prior years. (e) Insurance expense represents the cost of insurance premiums.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Significant Accounting Policies [Line Items]
Customary payment description	Customary payment terms are 2% 30 days
Bad debt expense in term	3 years
Advertising expenses	$ 3.4	$ 3.1	$ 2.4
Shipping costs	4.3	4.4	4.7
Research and development	$ 8.2	$ 9.8	$ 9.6
Building [Member]
Significant Accounting Policies [Line Items]
Useful life	15 years
Machinery and Equipment [Member]
Significant Accounting Policies [Line Items]
Useful life	7 years
Tools, Dies and Molds [Member]
Significant Accounting Policies [Line Items]
Useful life	3 years
Firearms [Member] | Customer Concentration Risk [Member] | Sales [Member]
Significant Accounting Policies [Line Items]
Percentage of sales	99%
Export Sales [Member] | Customer Concentration Risk [Member] | Sales [Member]
Significant Accounting Policies [Line Items]
Percentage of sales	5%
Castings Sales [Member] | Customer Concentration Risk [Member] | Sales [Member]
Significant Accounting Policies [Line Items]
Percentage of sales	1%

Revenue Recognition and Contr_3

Revenue Recognition and Contracts with Customers (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2024
Revenue Recognition and Contracts with Customers [Abstract]
Revenue and recognized	$ 4.1		$ 0.1
Net increase in firearms sales	0.9		0.1
Deferred contract revenue liability	0.1	$ 1
Deferred of revenue	$ 3.2	1
Net decrease in firearms sales		$ 1

Revenue Recognition and Contr_4

Revenue Recognition and Contracts with Customers - Schedule of Revenue Recognized (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Schedule of Revenue Recognized [Abstract]
Contract liabilities with customers at beginning of period	$ 149	$ 1,031
Revenue recognized	(149)	(4,084)
Revenue deferred		3,202	1,031
Contract liabilities with customers at end of period		$ 149	$ 1,031

Trade Receivables, Net (Details

Trade Receivables, Net (Details) - Customer Concentration Risk [Member] - Accounts Receivable [Member]	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Customer One [Member]
Trade Receivables, Net [Line Items]
Total trade receivables	26%	22%
Customer Two [Member]
Trade Receivables, Net [Line Items]
Total trade receivables	20%	20%
Customer Three [Member]
Trade Receivables, Net [Line Items]
Total trade receivables	14%	17%
Customer Four [Member]
Trade Receivables, Net [Line Items]
Total trade receivables	11%

Trade Receivables, Net - Schedu

Trade Receivables, Net - Schedule of Trade Receivables (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Schedule of Trade Receivables [Abstract]
Trade receivables	$ 68,855	$ 61,428
Allowance for doubtful accounts	(400)	(400)
Allowance for discounts	(1,310)	(1,164)
Total trade receivables	$ 67,145	$ 59,864

Inventories - Schedule of Inven

Inventories - Schedule of Inventories (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Inventory at FIFO
Finished goods	$ 26,022	$ 30,989
Materials and products in process	123,395	119,203
Gross inventories	149,417	150,192
Less: LIFO reserve	(66,398)	(64,262)
Less: excess and obsolescence reserve	(6,533)	(6,120)
Net inventories	$ 76,486	$ 79,810

Property, Plant and Equipment_2

Property, Plant and Equipment (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 21,106	$ 21,115	$ 24,444

Property, Plant and Equipment -

Property, Plant and Equipment - Schedule of Property, Plant and Equipment (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Property, plant and equipment	$ 477,622	$ 462,397
Less allowances for depreciation	(406,373)	(390,863)
Net property, plant and equipment	71,249	71,534
Land Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment	2,826	2,826
Building and Building Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment	76,153	74,650
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment	333,365	322,730
Dies and Tools [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment	$ 65,278	$ 62,191

Other Assets (Details)

Other Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Other Assets (Details) [Line Items]
Patent amortization	$ 0.5	$ 0.4	$ 0.4
Estimated annual patent amortization expense after five years	0.4
Trade Name[Member]
Other Assets (Details) [Line Items]
Estimated annual patent amortization expense 2024	0.4
Estimated annual patent amortization expense 2025	0.4
Estimated annual patent amortization expense 2026	0.4
Estimated annual patent amortization expense 2027	0.4
Estimated annual patent amortization expense 2028	0.4
Customer Relationships [Member]
Other Assets (Details) [Line Items]
Estimated annual patent amortization expense 2024	0.1
Estimated annual patent amortization expense 2025	0.1
Estimated annual patent amortization expense 2026	0.1
Estimated annual patent amortization expense 2027	0.1
Estimated annual patent amortization expense 2028	$ 0.1

Other Assets - Schedule of Othe

Other Assets - Schedule of Other Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Schedule Of Other Assets Abstract
Patents, at cost	$ 10,339	$ 10,280
Deposits on capital items	18,443	23,045
Marlin trade name, at cost	7,800	7,800
Accumulated amortization	(8,008)	(7,171)
Other	9,173	9,958
Other assets	$ 37,747	$ 43,912

Leased Assets (Details)

Leased Assets (Details)	Dec. 31, 2024	Dec. 31, 2023
Leased Assets [Abstract]
Lease term	7 years 8 months 12 days	7 years 10 months 24 days

Leased Assets - Schedule of Rig

Leased Assets - Schedule of Right-of-Use Assets and Related Lease Liabilities (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Leased Assets - Schedule of Right-of-Use Assets and Related Lease Liabilities (Details) [Line Items]
Operating Lease, Liability, Noncurrent	$ 1,747	$ 2,170
Operating Lease, Liability	2,345	2,781
Operating Lease, Payments	796	796
Short-Term Lease Payments	449	565
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability
Operating Lease, Weighted Average Remaining Lease Term	7 years 8 months 12 days	7 years 10 months 24 days
Operating Lease, Weighted Average Discount Rate, Percent	8%	5%
Other Assets [Member]
Leased Assets - Schedule of Right-of-Use Assets and Related Lease Liabilities (Details) [Line Items]
Operating Lease, Right-of-Use Asset	$ 2,345	$ 2,781
Trade accounts payable and accrued expenses [Member]
Leased Assets - Schedule of Right-of-Use Assets and Related Lease Liabilities (Details) [Line Items]
Operating Lease, Liability, Current	598	611
Lease liabilities [Member]
Leased Assets - Schedule of Right-of-Use Assets and Related Lease Liabilities (Details) [Line Items]
Operating Lease, Liability, Noncurrent	$ 1,747	$ 2,170

Leased Assets - Schedule of Ope

Leased Assets - Schedule of Operating Lease Liabilities Future Minimum Lease Payments (Details) - Operating lease [Member] $ in Thousands	Dec. 31, 2024 USD ($)
Schedule of Operating Lease Liabilities Future Minimum Lease Payments [Line items]
2025	$ 765
2026	771
2027	295
2028	160
2029	160
Thereafter	800
Total undiscounted future minimum lease payments	2,951
Less: Difference between undiscounted lease payments & the present value of future lease payments	(606)
Total operating lease liabilities	$ 2,345

Trade Accounts Payable and Ac_3

Trade Accounts Payable and Accrued Expenses - Schedule of Trade Accounts Payable and Accrued Expenses (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Schedule of Trade Accounts Payable and Accrued Expenses [Abstract]
Trade accounts payable	$ 13,170	$ 11,100
Federal excise taxes payable	13,192	11,954
Accrued other	9,388	8,654
Trade accounts payable and accrued expenses	$ 35,750	$ 31,708

Accrued Dividends (Details)

Accrued Dividends (Details) - USD ($) $ / shares in Units, $ in Millions	Jan. 05, 2023	Nov. 30, 2022
Accrued Dividends (Details) [Line Items]
Dividend payable per share		$ 5
Dividends Payable	$ 88.3
S2022Q4 Dividends [Member]
Accrued Dividends (Details) [Line Items]
Dividends payable, date of record		Dec. 15, 2022
Dividends payable, date to be paid	Jan. 05, 2023

Line of Credit (Details)

Line of Credit (Details) - USD ($) $ in Millions	Jun. 06, 2024	Jan. 07, 2022
Line of Credit [Line Items]
Line of credit agreement		$ 40
Revolving credit facility, expiration date	Jan. 07, 2028
Line of credit unused portion per year	0.25%

Employee Benefit Plans (Details

Employee Benefit Plans (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Employee Benefit Plans [Abstract]
Expenses related to matching employee contributions	$ 4.1	$ 4.7	$ 4.1
Supplemental contributions total	$ 7	$ 6.9	$ 7.4

Other Operating Income, Net - S

Other Operating Income, Net - Schedule of Other Operating Income, Net (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Schedule of Other Operating Income, Net [Abstract]
Gain on sale of operating assets		$ 5	$ 36

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Taxes (Details) [Line Items]
Effective tax rate		19.10%	18%	18.40%
Capitalized and amortized over for income tax purposes		5 years
Income tax payments		$ 10.6	$ 26	$ 28.7
Forecast [Member]
Income Taxes (Details) [Line Items]
Effective tax rate	20.30%

Income Taxes - Schedule of Fede

Income Taxes - Schedule of Federal and State Income Tax Provision (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Schedule of Federal and State Income Tax Provision [Abstract]
Federal, current	$ 10,310	$ 14,763	$ 21,741
Federal, deferred	(4,190)	(5,285)	(4,694)
State, current	1,607	1,713	3,779
State, deferred	(515)	(582)	(879)
Current	11,917	16,476	25,520
Deferred	$ (4,705)	$ (5,867)	$ (5,573)

Income Taxes - Schedule of Effe

Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Schedule of Effective Income Tax Rate Reconciliation [Abstract]
Statutory federal income tax rate	21%	21%	21%
State income taxes, net of federal tax benefit	1.50%	2.20%	2.70%
Research and development tax credits	(5.90%)	(2.70%)	(4.20%)
Other	2.50%	(2.50%)	(1.10%)
Effective income tax rate	19.10%	18%	18.40%

Income Taxes - Schedule of Defe

Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Deferred tax assets
Capitalized research and development costs	$ 12,566	$ 9,144
Employee compensation and benefits	2,483	2,452
Allowances for doubtful accounts and discounts	452	431
Inventories	1,831	1,635
Stock-based compensation	1,876	1,698
Other	1,537	1,608
Total deferred tax assets	20,745	16,968
Deferred tax liabilities:
Depreciation	2,868	3,578
Other	1,196	1,414
Total deferred tax liabilities	4,064	4,992
Net deferred tax assets	$ 16,681	$ 11,976

Earnings Per Share - Schedule o

Earnings Per Share - Schedule of a Reconciliation of the Numerator and Denominator for the Basic and Diluted Earnings Per Share (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2024	Sep. 28, 2024	Jun. 29, 2024	Mar. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Jul. 01, 2023	Apr. 01, 2023	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Numerator:
Net income (in Dollars)	$ 10,477	$ 4,738	$ 8,264	$ 7,084	$ 10,249	$ 7,431	$ 16,185	$ 14,350	$ 30,563	$ 48,215	$ 88,332
Denominator:
Weighted average number of common shares outstanding – Basic									17,088,205	17,676,955	17,648,850
Dilutive effect of options and restricted stock units outstanding under the Company’s employee compensation plans									181,896	134,263	144,498
Weighted average number of common shares outstanding – Diluted									17,270,101	17,811,218	17,793,348

Stock Repurchases (Details)

Stock Repurchases (Details)	Dec. 31, 2024 USD ($)
Stock Repurchases [Abstract]
Share repurchase authorization	$ 40,290,000

Stock Repurchases - Schedule of

Stock Repurchases - Schedule of Repurchased Shares of its Common Stock (Details) - USD ($)	3 Months Ended
	Dec. 31, 2024	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Sep. 30, 2022
Schedule of Repurchased Shares [Line Items]
Total Number of Shares Purchased	1,103,562
Average Price Paid per Share (in Dollars per share)	$ 42.07
Total Number of Shares Purchased as Part of Publicly Announced Program	1,103,562
Maximum Dollar Value of Shares that May Yet Be Purchased Under the Program (in Dollars)	$ 40,290,000
July 3 to July 30 [Member] | Third Quarter 2022 [Member]
Schedule of Repurchased Shares [Line Items]
Total Number of Shares Purchased
Average Price Paid per Share (in Dollars per share)
Total Number of Shares Purchased as Part of Publicly Announced Program
July 31 to August 27 [Member] | Third Quarter 2022 [Member]
Schedule of Repurchased Shares [Line Items]
Total Number of Shares Purchased
Average Price Paid per Share (in Dollars per share)
Total Number of Shares Purchased as Part of Publicly Announced Program
August 28 to October 1 [Member] | Third Quarter 2022 [Member]
Schedule of Repurchased Shares [Line Items]
Total Number of Shares Purchased							2,136
Average Price Paid per Share (in Dollars per share)							$ 49.97
Total Number of Shares Purchased as Part of Publicly Announced Program							2,136
October 2 to October 29 [Member] | Fourth Quarter 2022 [Member]
Schedule of Repurchased Shares [Line Items]
Total Number of Shares Purchased
Average Price Paid per Share (in Dollars per share)
Total Number of Shares Purchased as Part of Publicly Announced Program
October 30 to November 26 [Member] | Fourth Quarter 2022 [Member]
Schedule of Repurchased Shares [Line Items]
Total Number of Shares Purchased						2,304
Average Price Paid per Share (in Dollars per share)						$ 49.77
Total Number of Shares Purchased as Part of Publicly Announced Program						2,304
November 27 to December 31 [Member] | Fourth Quarter 2022 [Member]
Schedule of Repurchased Shares [Line Items]
Total Number of Shares Purchased
Average Price Paid per Share (in Dollars per share)
Total Number of Shares Purchased as Part of Publicly Announced Program
October 1 to October 28 [Member] | Fourth Quarter 2023 [Member]
Schedule of Repurchased Shares [Line Items]
Total Number of Shares Purchased
Average Price Paid per Share (in Dollars per share)
Total Number of Shares Purchased as Part of Publicly Announced Program
October 29 to November 25 [Member] | Fourth Quarter 2023 [Member]
Schedule of Repurchased Shares [Line Items]
Total Number of Shares Purchased					179,341
Average Price Paid per Share (in Dollars per share)					$ 45.2
Total Number of Shares Purchased as Part of Publicly Announced Program					179,341
November 26 to December 31 [Member] | Fourth Quarter 2023 [Member]
Schedule of Repurchased Shares [Line Items]
Total Number of Shares Purchased					84,721
Average Price Paid per Share (in Dollars per share)					$ 43.67
Total Number of Shares Purchased as Part of Publicly Announced Program					84,721
January 1 to January 27 [Member] | First Quarter 2024 [Member]
Schedule of Repurchased Shares [Line Items]
Total Number of Shares Purchased				7,317
Average Price Paid per Share (in Dollars per share)				$ 43.42
Total Number of Shares Purchased as Part of Publicly Announced Program				7,317
January 28 to February 24 [Member] | First Quarter 2024 [Member]
Schedule of Repurchased Shares [Line Items]
Total Number of Shares Purchased				20,307
Average Price Paid per Share (in Dollars per share)				$ 42.93
Total Number of Shares Purchased as Part of Publicly Announced Program				20,307
February 25 to March 30 [Member] | First Quarter 2024 [Member]
Schedule of Repurchased Shares [Line Items]
Total Number of Shares Purchased				47,400
Average Price Paid per Share (in Dollars per share)				$ 42.79
Total Number of Shares Purchased as Part of Publicly Announced Program				47,400
March 31 to April 27 [Member] | Second Quarter 2024 [Member]
Schedule of Repurchased Shares [Line Items]
Total Number of Shares Purchased
Average Price Paid per Share (in Dollars per share)
Total Number of Shares Purchased as Part of Publicly Announced Program
April 28 to May 25 [Member] | Second Quarter 2024 [Member]
Schedule of Repurchased Shares [Line Items]
Total Number of Shares Purchased			28,924
Average Price Paid per Share (in Dollars per share)			$ 42.92
Total Number of Shares Purchased as Part of Publicly Announced Program			28,924
May 26 to June 29 [Member] | Second Quarter 2024 [Member]
Schedule of Repurchased Shares [Line Items]
Total Number of Shares Purchased			373,969
Average Price Paid per Share (in Dollars per share)			$ 42.27
Total Number of Shares Purchased as Part of Publicly Announced Program			373,969
June 30 to July 27 [Member] | Third Quarter 2024 [Member]
Schedule of Repurchased Shares [Line Items]
Total Number of Shares Purchased		156,517
Average Price Paid per Share (in Dollars per share)		$ 41.27
Total Number of Shares Purchased as Part of Publicly Announced Program		156,517
July 28 to August 24 [Member] | Third Quarter 2024 [Member]
Schedule of Repurchased Shares [Line Items]
Total Number of Shares Purchased
Average Price Paid per Share (in Dollars per share)
Total Number of Shares Purchased as Part of Publicly Announced Program
August 25 to September 28 [Member] | Third Quarter 2024 [Member]
Schedule of Repurchased Shares [Line Items]
Total Number of Shares Purchased		64,325
Average Price Paid per Share (in Dollars per share)		$ 40.66
Total Number of Shares Purchased as Part of Publicly Announced Program		64,325
September 29 to October 26 [Member] | Fourth Quarter 2024 [Member]
Schedule of Repurchased Shares [Line Items]
Total Number of Shares Purchased	11,340
Average Price Paid per Share (in Dollars per share)	$ 40.5
Total Number of Shares Purchased as Part of Publicly Announced Program	11,340
October 27 to November 23 [Member] | Fourth Quarter 2024 [Member]
Schedule of Repurchased Shares [Line Items]
Total Number of Shares Purchased	52,129
Average Price Paid per Share (in Dollars per share)	$ 39.5
Total Number of Shares Purchased as Part of Publicly Announced Program	52,129
November 23 to December 31 [Member] | Fourth Quarter 2024 [Member]
Schedule of Repurchased Shares [Line Items]
Total Number of Shares Purchased	72,832
Average Price Paid per Share (in Dollars per share)	$ 34.81
Total Number of Shares Purchased as Part of Publicly Announced Program	72,832

Compensation Plans (Details)

Compensation Plans (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	May 31, 2017
Compensation Plans [Line Items]
Total stock-based compensation	$ 5.8	$ 6.2	$ 5.7
Unrecognized compensation cost	1
Deferred Stock [Member]
Compensation Plans [Line Items]
Compensation expense	$ 0.9	$ 0.9	$ 0.8
Restricted Stock Units (RSUs) [Member]
Compensation Plans [Line Items]
Restricted stock units issued (in Shares)	153,000	114,000	82,000
Cost of issuances restricted stock units	$ 6.8	$ 6.1	$ 6
Recognized costs of restricted stock units	$ 1.9	$ 1.3	$ 1.7
Vesting period	3 years 3 months 18 days
Unrecognized compensation cost	$ 7.8
Minimum [Member] | Restricted Stock Units (RSUs) [Member]
Compensation Plans [Line Items]
Vesting period	24 months	24 months	24 months
Maximum [Member] | Restricted Stock Units (RSUs) [Member]
Compensation Plans [Line Items]
Vesting period	26 months	26 months	26 months
Director [Member] | Vest In June2025 [Member] | Deferred Stock [Member]
Compensation Plans [Line Items]
Deferred stock awards amount (in Shares)	9,291
Director [Member] | Vest in June 2027 [Member] | Deferred Stock [Member]
Compensation Plans [Line Items]
Deferred stock awards amount (in Shares)	11,992		1,478
Director [Member] | Vest In June 2024 [Member] | Deferred Stock [Member]
Compensation Plans [Line Items]
Deferred stock awards amount (in Shares)		7,566
Director [Member] | Vest in June 2026 [Member] | Deferred Stock [Member]
Compensation Plans [Line Items]
Deferred stock awards amount (in Shares)		9,760
Director [Member] | Vest in May 2023 [Member] | Deferred Stock [Member]
Compensation Plans [Line Items]
Deferred stock awards amount (in Shares)			5,953
Director [Member] | Vesting in May 2025 [Member] | Deferred Stock [Member]
Compensation Plans [Line Items]
Deferred stock awards amount (in Shares)			7,688
Stock Incentive Plan 2017 [Member]
Compensation Plans [Line Items]
Shares reserved for future issuance (in Shares)				750,000
Stock Incentive Plan 2023 [Member]
Compensation Plans [Line Items]
Reserved shares for future issuance (in Shares)		1,000,000
Shares available for future grants (in Shares)	845,000

Operating Segment Information_2

Operating Segment Information (Details) - segments	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Operating Segment Information [Line Items]
Reportable operating segments (in segments)	2
Customer Concentration Risk [Member] | Lipsey’s [Member] | Revenue Benchmark [Member]
Operating Segment Information [Line Items]
Percentage of sales	28%	24%	23%
Customer Concentration Risk [Member] | Sports South [Member] | Revenue Benchmark [Member]
Operating Segment Information [Line Items]
Percentage of sales	18%	15%	21%
Customer Concentration Risk [Member] | Davidson’s [Member] | Revenue Benchmark [Member]
Operating Segment Information [Line Items]
Percentage of sales	16%	19%	23%
Customer Concentration Risk [Member] | United State [Member] | Revenue Benchmark [Member]
Operating Segment Information [Line Items]
Percentage of sales	94%	94%	94%

Operating Segment Information -

Operating Segment Information - Schedule of Operating Segment Financial Information (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2024	Sep. 28, 2024	Jun. 29, 2024	Mar. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Jul. 01, 2023	Apr. 01, 2023	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Net Sales
Net Sales	$ 145,775	$ 122,287	$ 130,761	$ 136,820	$ 130,617	$ 120,893	$ 142,804	$ 149,453	$ 535,643	$ 543,767	$ 595,842
Costs of Goods Sold
Costs of Goods Sold									421,228	410,148	415,757
Gross Profit (Loss)
Gross Profit (Loss)	33,186	$ 22,672	$ 29,154	$ 29,403	32,257	$ 24,728	$ 38,148	$ 38,486	114,415	133,619	180,085
Operating Income (Loss)
Operating Income (Loss)									31,654	52,084	103,456
Income (Loss) Before Income Taxes
Income (Loss) Before Income Taxes									37,775	58,824	108,279
Identifiable Assets
Identifiable Assets	384,034				398,817				384,034	398,817	484,763
Goodwill
Goodwill	3,264				3,264				3,264	3,264	3,264
Depreciation
Depreciation									21,106	21,115	24,444
Capital Expenditures
Capital Expenditures									20,821	15,796	27,773
Firearms [Member]
Net Sales
Net Sales									532,608	540,746	593,289
Costs of Goods Sold
Costs of Goods Sold									417,222	407,068	410,507
Gross Profit (Loss)
Gross Profit (Loss)									115,386	133,678	182,782
Operating Income (Loss)
Operating Income (Loss)									33,273	52,887	106,803
Income (Loss) Before Income Taxes
Income (Loss) Before Income Taxes									34,051	53,723	108,609
Identifiable Assets
Identifiable Assets	230,024				228,699				230,024	228,699	223,301
Goodwill
Goodwill	3,055				3,055				3,055	3,055	3,055
Depreciation
Depreciation									19,952	19,301	21,992
Capital Expenditures
Capital Expenditures									20,488	15,395	26,598
Castings Unaffiliated [Member] | Castings [Member]
Castings
Net Sales for Castings									3,035	3,021	2,553
Costs of Goods Sold
Costs of Goods Sold									4,006	3,080	5,250
Intersegment [Member] | Castings [Member]
Castings
Net Sales for Castings									31,528	33,086	21,306
Costs of Goods Sold
Costs of Goods Sold									31,528	33,086	21,306
Castings [Member]
Castings
Net Sales for Castings									34,563	36,107	23,859
Costs of Goods Sold
Costs of Goods Sold									35,534	36,166	26,556
Gross Profit (Loss)
Gross Profit (Loss)									(971)	(59)	(2,697)
Operating Income (Loss)
Operating Income (Loss)									(1,619)	(803)	(3,347)
Income (Loss) Before Income Taxes
Income (Loss) Before Income Taxes									(1,616)	(799)	(3,338)
Identifiable Assets
Identifiable Assets	9,303				11,144				9,303	11,144	11,910
Goodwill
Goodwill	209				209				209	209	209
Depreciation
Depreciation									1,154	1,814	2,452
Capital Expenditures
Capital Expenditures									333	401	1,175
Eliminations [Member]
Net Sales
Net Sales									(31,528)	(33,086)	(21,306)
Costs of Goods Sold
Costs of Goods Sold									(31,528)	(33,086)	(21,306)
Corporates [Member]
Income (Loss) Before Income Taxes
Income (Loss) Before Income Taxes									5,340	5,900	3,008
Identifiable Assets
Identifiable Assets	$ 144,707				$ 158,974				$ 144,707	$ 158,974	$ 249,552

Quarterly Results of Operatio_3

Quarterly Results of Operations (Unaudited) - Schedule of Quarterly Financial Information (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2024	Sep. 28, 2024	Jun. 29, 2024	Mar. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Jul. 01, 2023	Apr. 01, 2023	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Schedule of Quarterly Financial Information [Abstract]
Net Sales	$ 145,775	$ 122,287	$ 130,761	$ 136,820	$ 130,617	$ 120,893	$ 142,804	$ 149,453	$ 535,643	$ 543,767	$ 595,842
Gross profit	33,186	22,672	29,154	29,403	32,257	24,728	38,148	38,486	114,415	133,619	180,085
Net income	$ 10,477	$ 4,738	$ 8,264	$ 7,084	$ 10,249	$ 7,431	$ 16,185	$ 14,350	$ 30,563	$ 48,215	$ 88,332
Basic earnings per share (in Dollars per share)	$ 0.63	$ 0.28	$ 0.48	$ 0.41	$ 0.58	$ 0.42	$ 0.91	$ 0.81	$ 1.79	$ 2.73	$ 5
Diluted earnings per share (in Dollars per share)	$ 0.62	$ 0.28	$ 0.47	$ 0.4	$ 0.58	$ 0.42	$ 0.91	$ 0.81	$ 1.77	$ 2.71	$ 4.96

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
National Rifle Association [Member]
Related Party Transactions [Line Items]
Amount paid	$ 0.5	$ 0.5	$ 0.7
National Shooting Sports Foundation [Member]
Related Party Transactions [Line Items]
Amount paid	$ 0.4	$ 0.3	$ 0.3

Contingent Liabilities (Details

Contingent Liabilities (Details) $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Contingent Liabilities [Line Items]
Minimum limit of per claim for providing insurance coverage on annual basis (in Dollars)	$ 5
Maximum limit of aggregate loss incurred annually for providing insurance coverage on annual basis (in Dollars)	$ 10
Total amount of damages claimed (in Dollars)				$ 1.1
Number of lawsuits			1
Number of lawsuits resolved	1
Number of lawsuits involving its products	8	7	5
Product liability expense (in Dollars)	$ 0.7	$ 1.5	$ 1.3
Product liability expense years	3 years
Trademark Litigation [Member]
Contingent Liabilities [Line Items]
Number of lawsuits	1
Trademark Lawsuit [Member]
Contingent Liabilities [Line Items]
Number of lawsuits	1
Traditional Product Liability Lawsuit [Member]
Contingent Liabilities [Line Items]
Number of lawsuits		1
Number of lawsuits resolved	1	1	1
Municipal Lawsuit [Member]
Contingent Liabilities [Line Items]
Number of lawsuits	4	4	4
Number of lawsuit dismissed	1
Unfair Trade Practices [Member]
Contingent Liabilities [Line Items]
Number of lawsuits	2	2
Negligence Lawsuit [Member]
Contingent Liabilities [Line Items]
Number of lawsuits		2	3

Contingent Liabilities - Schedu

Contingent Liabilities - Schedule of Roll-forward for Product Liability Reserve (Details) - Product Liability Reserve Member [Member] - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Product Warranty Liability [Line Items]
Balance Beginning of Year	[1]	$ 679	$ 308	$ 892
Accrued Legal Expense (Income)	[2]	67	500	(417)
Legal Fees	[3]	(254)	(129)	(167)
Settlements	[4]
Balance End of Year	[1]	$ 492	$ 679	$ 308
[1]The beginning and ending liability balances represent accrued legal fees only. Settlements and administrative costs are expensed as incurred. Only in rare instances is an accrual established for settlements.[2]The expense accrued in the liability is for legal fees only. In 2022, the costs incurred related to cases that were settled or dismissed were less than the amounts accrued for these cases in prior years.[3]Legal fees represent payments to outside counsel related to product liability matters.[4]Settlements represent payments made to plaintiffs or allegedly injured parties in exchange for a full and complete release of liability.

Contingent Liabilities - Sche_2

Contingent Liabilities - Schedule of Product Liability Expense (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Accrued Legal Expense [Member]
Product Liability Contingency [Line Items]
Accrued Legal Expense	[1]	$ 67	$ 500	$ (417)
Insurance Premium Expense [Member]
Product Liability Contingency [Line Items]
Insurance Premium Expense	[2]	908	1,226	1,524
Total Product Liability Expense [Member]
Product Liability Contingency [Line Items]
Total Product Liability Expense		$ 975	$ 1,726	$ 1,107
[1]The expense accrued in the liability is for legal fees only. In 2022, the costs incurred related to cases that were settled or dismissed were less than the amounts accrued for these cases in prior years.[2]Insurance expense represents the cost of insurance premiums.

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event [Member]	Feb. 14, 2025 $ / shares
Subsequent Event [Line Items]
Dividend authorized	$ 0.24
Date of record	Mar. 14, 2025